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ABSTRACT 
 
DESIGN PRINCIPLES OF MAMMALIAN TRANSCRIPTIONAL REGULATION  
Caroline R. Bartman 
Gerd A. Blobel 
Arjun Raj 
Transcriptional regulation occurs via changes to different biochemical steps of transcription, but it 
remains unclear which steps are subject to change upon biological perturbation. Single cell 
studies have revealed that transcription occurs in discontinuous bursts, suggesting that features 
of such bursts like burst fraction (what fraction of time a gene spends transcribing RNA) and burst 
intensity could be points of transcriptional regulation. Both how such features might be regulated 
and the prevalence of such modes of regulation are unclear. I first used a synthetic transcription 
factor to increase enhancer-promoter contact at the β -globin locus. Increasing promoter-
enhancer contact specifically modulated the burst fraction of β -globin in both immortalized 
mouse and primary human erythroid cells. This finding raised the question of how generally 
important the phenomenon of burst fraction regulation might be, compared to other modes of 
regulation. For example, biochemical studies have suggested that stimuli predominantly affect the 
rate of RNA polymerase II (Pol II) binding and the rate of Pol II release from promoter-proximal 
pausing, but the prevalence of these modes of regulation compared to changes in bursting had 
not been examined.  I combined Pol II ChIP-seq and single cell transcriptional measurements to 
reveal that an independently regulated burst initiation step is required before polymerase binding 
can occur, and that the change in burst fraction produced by increased enhancer-promoter 
contact was caused by an increased burst initiation rate. Using a number of global and targeted 
transcriptional regulatory perturbations, I showed that biological perturbations regulated both 
burst initiation and polymerase pause release rates, but seemed not to regulate polymerase 
binding rate. Our results suggest that transcriptional regulation primarily acts by changing the 
rates of burst initiation and polymerase pause release. 
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CHAPTER 1: Introduction 
 
 My graduate work focused on the broad question of how cells can change their state in 
response to stimuli. The cells of a eukaryotic organism all share the same genome; however, they 
differentiate from a single zygote into many different cell types that carry out different functions 
mediated by the expression of cell-type-specific suites of proteins. A major focus of biological 
science has been to understand how cells with the same genome can induce and maintain such 
divergent functional states. Relatedly, eukaryotic cells must be able to respond quickly to certain 
stimuli by changing protein expression: canonical examples of such stimuli include heat shock or 
inflammatory signals. Both cell-type identity and functional responses to signaling are chiefly 
governed at the level of DNA transcription into RNA, though other processes like protein post-
translational modification and degradation also play important roles. Thus, understanding how 
eukaryotic cells induce and maintain the transcription of a set of genes is critical to understanding 
the function, health, and disease of eukaryotic organisms. Below, I will review the key aspects of 
transcriptional regulation of higher eukaryotes that have formed the basis for my graduate work. 
Figure 1.1 shows a schematized outline of this Introduction. 
 
 
Figure 1. 1: Schematic of the events of RNA polymerase II transcription in mammalian cells, 
highlighting steps that will be reviewed in this Introduction. 
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1.1 Transcription Factors Orchestrate Cell Function 
 RNA transcription is a complex process which is governed at multiple levels, but arguably 
the prime movers in this process are transcription factors. Transcription factors are proteins that 
bind cognate target sequences in genomic DNA in order to induce or repress transcription. These 
factors can be sufficient to determine cellular function: for example, expressing certain sets of 
transcription factors can overwrite a cell’s initial transcriptional program, and reprogram cells into 
a new cell type including dedifferentiating cells into fully pluripotent embryonic stem cells1. 
Conversely, transcription factors can also be necessary to establish cell type identity: certain 
transcription factors are absolutely required for differentiation of a given cell type, such as GATA-
1 in erythroid cells2, which will be further described at the end of this section. 
 Broadly, each transcription factor carries out its function using two modular domains: a 
DNA binding domain and a transcriptional transactivation domain3. The DNA-binding domain 
mediates sequence-specific binding to DNA. Many different families of conserved binding 
elements have been crystallized, and each structure confers a stereotypical type of DNA 
sequence recognition4–6. The quality and stringency of sequence specificity varies widely 
depending on the transcription factor, ranging from short motifs around 6-10 base pairs long with 
a wide range of degeneracy permitted to highly specific motifs up to 20 base pairs long in the 
case of CTCF7–9 . Such transcription factor recognition sequences have been identified both 
using in vitro protein-DNA binding assays and by measuring binding in cells to plasmids or 
genomic DNA using methods such as chromatin immunoprecipitation (ChIP)7. Transcription 
factors bind to influence transcription of genes at two main types of locations in the genome: 
proximal to the transcriptional start site, in the region known as the gene promoter, or at distal 
regulatory regions known as enhancers (both discussed in detail below).  
However, motif recognition is not sufficient to predict genome-wide transcription factor 
binding: many factors fail to bind the majority of their consensus motifs in the genome8 . Beyond 
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direct sequence recognition, transcription factor binding is also influenced by the local sequence 
context surrounding its recognition motif. For example, clusters of binding sites serve to give a 
region a higher avidity for a transcription factor, and thus can raise the likelihood of transcription 
factor binding to a region10. The spacing between such binding motif sites may also influence the 
likelihood of transcription factor binding11–13. Binding of different transcription factors nearby can 
also promote transcription factor binding14–17. Such cooperative binding can be mediated by direct 
protein-protein interactions (for example in the case of GATA-1 and Tal1, described below), or by 
one factor helping to displace nucleosomes away from a second factor’s binding site7 .There is 
also evidence that factors can promote each other’s binding indirectly via bending of DNA18–20.  
 However, even sequence context is often not sufficient to predict genome-wide 
transcription factor binding patterns, due to other factors that influence binding. For example, 
genomic DNA in eukaryotic cells is wrapped around protein octamers known as nucleosomes, 
and nucleosome binding can block transcription factor binding21–24. However, certain transcription 
factors, known as ‘pioneer factors’, possess the ability to recognize partial cognate sites on 
nucleosome-bound DNA23,25. These factors can recruit nucleosome remodelers such as the 
Swi/SNF complex, which can remove nucleosomes to allow further non-pioneer factors to bind 
their cognate sites23,25. Such pioneer properties are thought to be critical in allowing regions of 
DNA to transition from the heterochromatinized state to a transcriptionally-accessible state, in 
which even transcription factors can access their cognate binding sites. Such a property is likely 
critical for cellular transdifferentiation, and also likely in normal cellular differentiation26,27. Given 
the complex interplay between transcription factor motif, nearby sequence context, and 
nucleosome occupancy, an open area of study addresses how to combine multiple types of data 
to predict transcription factor binding with better accuracy, to ultimately be able to reconstruct the 
mechanisms driving gene regulation in a given cell type17,28.  
 Once a transcription factor successfully binds a cognate site, it must then carry out its 
function of transcriptional activation or suppression mediated by its transactivation domain. 
Transactivation domains are often characterized by an abundance of acidic residues3,29. These 
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domains can mediate their function by recruiting activating or repressive complexes, which can 
post-translationally modify surrounding histones with repressive or activating marks or can 
remodel nucleosomes to promote transcription factor binding and transcription itself7,30. For 
example, the interferon-beta enhancer supports the binding of multiple transcription factors, which 
ultimately results in the recruitment of acetyltransferases such as CBP/p300 to promote 
transcription of the interferon gene20. On the other hand, many zinc-finger transcription factors 
use their repressive KRAB domains to recruit a complex which imposes histone-3 lysine-9 
trimethylation to silence transcription of a target region31. However, such black and white cases 
as repressive zinc fingers may be the exception rather than the rule: in many cases, the same 
transcription factor domain can recruit either activating or repressing complexes in a context 
dependent manner: GATA-1 described below is one such example7,30. Thus, neighboring factor 
binding can influence both the DNA binding and the transactivation properties of a given factor. 
Transactivating domains have been more challenging to study structurally than DNA-
binding domains of transcription factors, since many of these domains are disordered and thus 
elude crystallization4. Currently, there is a resurgence of interest in these disordered domains 
because of these same physical properties: some have hypothesized that such disordered 
protein domains may be able to drive transcription via ‘condensation’ of protein complexes using 
a phase separation mechanism18,32–34. Phase separation is the phenomenon that many weak 
cooperative interactions between multivalent molecules can bring together clusters of proteins 
that appear to behave similarly to liquid droplets, displaying properties like excluding outside 
proteins and flowing18,33. Such phase-separation interactions can be promoted by post-
translational modifications of disordered protein domains, such as the phosphorylation of the C-
terminal domain of Pol II itself and phosphorylation of other transcription factors18,35,36. This type 
of condensation-based interaction is proposed to drive the nucleation of the clusters of 
transcription factors and of Pol II that have recently been observed by high-resolution imaging in 
live cells37,38. Phase separation control of transcription will be a very exciting area of study, but it 
is challenging to disentangle the role of the physical properties conferred by such disordered 
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regions of transcription factors from more conventional mechanisms of interaction with and 
recruitment of protein partners.  
 
1.1a: The GATA-1 transcription factor 
In my work and in other studies from the Blobel lab, we have taken advantage of the 
requirement for the transcription factor GATA-1 in the red blood cell transcriptional program in 
order to differentiate red blood cells in an inducible manner. GATA-1 was the first-discovered 
member of the GATA transcription factor family, members of which bind to a (A/T)GATA(A/G) 
motif in the genome39–41. GATA-1 was first isolated due to its binding to the beta-globin locus in 
red blood cells41,42. Its induction in granulocyte-monocyte progenitors drives differentiation of 
precursors into red blood cells and megakaryocytes41. As a result of its necessity in these cellular 
programs, embryonic stem cells lacking GATA-1 can contribute to every tissue in mice except red 
blood cells and megakaryocytes43,44, and mice lacking GATA-1 die at embryonic day 10.5 as a 
result of severe anemia2. GATA-1 is highly conserved from mice to humans, and humans with 
GATA-1 mutations display anemia and thrombocytopenia45,46.  
GATA-1 is an example of a transcription factor which both induces some genes and 
represses others in a context-dependent manner. Other transcription factors binding near GATA-
1 at a specific binding site seem to govern whether activating or repressive complexes are 
recruited to a GATA-1 binding site47. For example, when Tal-1 and GATA-1 bind together, this 
combination tends to produce transcriptional activation due to direct protein-protein interaction 
between the factors; indeed, mutations of the surface of GATA-1 where it contacts Tal-1 reduces 
its ability to activate transcription 46. However, at the majority of its sites GATA-1 mediates 
transcriptional repression, and thus it helps red blood cells to globally shut down transcription 
during their differentiation41. At such repressive binding sites, GATA-1 tends to bind alone in the 
absence of the Tal-1/SCL complex47. Such repression is mediated by the recruitment of the 
NuRD histone deacetylase complex by the GATA-1 binding partner FOG-147,48. 
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Taking advantage of GATA-1’s necessity and sufficiency for erythroid differentiation, 
Weiss and colleagues knocked out this factor in a mouse erythroid precursor cell line thus 
blocking differentiation, and then re-inserted a GATA-1-estradiol receptor fusion transgene, 
creating the ‘G1E-ER4’ cell line49–51. Upon treatment with estradiol, GATA-1 protein is stabilized 
and induces a highly reproducible differentiation cascade similar to red blood cell differentiation in 
vivo49–51. G1E-ER4 cells exposed to estradiol undergo terminal differentiation similarly to red 
blood cells in vivo, inducing transcription of genes typical of the erythroid lineage including the 
Slc4a1 (Band3) anion channel, the Slc25a37 iron transport channel, and the alpha- and beta-
globin subunits of hemoglobin52–54. This suite of proteins ultimately causes these cells to 
hemoglobinize and turn red, allowing visual tracking of their differentiation55, and to suppress 
transcription of almost all genes, although cells do not fully progress to enucleation unlike their in 
vivo counterparts. These G1E-ER4 cells also repress stem-cell associated proteins that maintain 
pluripotency and the stem-cell transcriptional program, including the Gata2 and Myc transcription 
factors, and the Kit cytokine receptor for stem cell factor cytokine53,54. This cell culture system 
thus represents a useful tool to study how a transcription factor can drive differentiation of a 
lineage and has been extensively previously characterized. I took advantage of these properties 
in my graduate work to compare this body of knowledge to the single-cell transcriptional 
properties produced by GATA-1 induction in these cells to better understand the regulation of 
transcriptional bursting.  
 
1.2 Transcriptional regulatory regions: promoters  
 Transcription factors exert their effects at promoters, near the beginning of genes, and at 
enhancers, or distal regulatory regions. In bacteria, promoters consist of highly conserved 
sequence motifs that directly recruit polymerase in order to drive transcription of genes56,57. 
Therefore, promoters were the first studied regulatory regions in eukaryotes, and at first were 
assume to completely govern transcription as in bacteria58. However, in higher eukaryotes, the 
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sequences of promoters were found to be quite variable between organisms and between 
different genes in the same organism56,59,60. Higher eukaryotes display some conserved 
categories of promoter motifs shared by multiple promoters, such as the TATA box and the 
Initiator (Inr) element, but such motifs are short (less than 10 base pairs on average) and 
relatively degenerate58,60. Higher eukaryotic promoters fall into two broad categories based on 
their transcriptional activating patterns: CpG promoters are rich in C and G nucleotides and tend 
to initiate transcription in a broader region and are often associated with housekeeping genes, 
while ‘narrow’ promoters which often have a TATA box drive transcription starting from a more 
focused location in the genome21,58,60. Promoters also typically display the histone 3 lysine 4 
trimethylation mark56. Promoters, especially ‘narrow’ promoters, also often include a well-placed 
nucleosomes at the transcription start site, which must be displaced in order for transcription to 
occur21,56. Due to the multiple categories of promoters with short and relatively degenerate motifs, 
higher eukaryotic promoters are difficult to identify using sequence alone: the gold standard 
techniques for promoter identification are experimental approaches that capture the 5’ starting 
end of transcripts with high sensitivity, such as GRO-seq or CAGE56,61. Eukaryotic promoters 
serve as the assembly point for the polymerase initiation complex, a highly orchestrated process 
that will be discussed further below. 
 
1.3 Transcriptional regulatory regions: enhancers  
 In higher eukaryotes, transcription factors binding at distal regulatory regions is critical to 
the establishment and maintenance of cell identity, perhaps as a result of the requirement for 
more complex spatial and temporal regulation associated with higher eukaryotic development 4. 
Distal regulatory elements acting in mammalian cells were first identified in the SV40 virus62. In 
mammalian systems, enhancers are typically a few hundred base pairs in length (though this can 
be altered depending on the approach used to define enhancers, as discussed below) 8. 
Enhancers can be located up to around a megabase from their target gene63–65 or can be quite 
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close to their target gene, although it becomes difficult within around a kilobase to definitionally 
distinguish an ‘enhancer’ from an extended promoter region. Enhancers can also typically 
function independent of their orientation with respect to their target gene66. These two properties, 
transcriptional activation at a distance and orientation independence, are the canonical defining 
characteristics of enhancers66.  
Enhancers consist of multiple transcription factor binding sites, often including sites for 
multiple different factors. A given enhancer is often active only in certain developmental and cell-
type contexts, in those contexts in which transcription factors are able to bind. In some situations, 
the assembly of this group of factors seems to occur in a specific order, and small sequence 
changes to the enhancer can abrogate all activating function8,67. However, in other cases, binding 
sites appear to drive transcription in a more additive manner, where different factors bind 
independent of each other to the same enhancer and each promotes enhancer activity68,69. A 
given gene can be controlled by different enhancers in different cellular contexts, such as in the 
case of the Myc gene63,64. The same gene can also be controlled by multiple distal regulatory 
regions, though whether these are considered to be separate enhancers or components of a 
massive ‘superenhancer’ can be somewhat semantic (discussed below)70,71 . 
Once transcription factors bind an enhancer, this complex must then activate 
transcription of the target gene by communicating to the promoter in some way. Enhancers are 
thought to promote transcription by transferring activating complexes to promoters or by 
increasing the local concentration of such activators. Transcriptional activators recruited by 
enhancers and brought to promoters include the CBP/p300 histone acetyltransferase complex 
and perhaps Pol II itself4. It has also been suggested that enhancers can transfer factors that help 
clear nucleosomes from promoters, or alternatively that enhancers can help promote promoter-
proximal pause release of Pol II8,72,73. However, the mechanisms of how enhancers confer 
transcriptional activity to promoters are still somewhat murky, since it is difficult to specifically 
perturb recruitment of complexes to specific sites in a targeted manner. 
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Different models of enhancer-promoter communication have been proposed: for 
example, that activating factors tracked linearly along the genome from an active enhancer to its 
target gene, or alternatively that the enhancer transfers activating factors directly by looping to its 
target gene66,74,75. The latter looping-type mechanisms have been supported by findings from 
chromatin conformation capture techniques, which use covalent cross-linking methods to 
sequence distal regions of DNA that contact each other in the nucleus76–78. Moreover, the Blobel 
lab showed that enhancer-promoter looping can be sufficient to cause transcriptional activation at 
the beta-globin locus79. Conversely, in several systems, transcription factor mutations or deletions 
that abrogate enhancer-promoter contact also reduce transcription, although in such cases the 
causative role of looping is unclear52,80,81. At other gene loci however enhancers contact 
promoters prior to transcriptional activation, suggesting that a further event independent of 
enhancer-promoter looping may be necessary for transcription82,83. More complexity is conferred 
by high-resolution imaging studies that showed that in some systems, enhancers and promoters 
were actually farther away (‘decondensed’) during active transcription compared to a 
developmental stage with no transcription84. In general, it has been extremely difficult to 
experimentally uncouple the role of promoter-enhancer contact from other events that occur 
during transcription. Live-imaging approaches (described more extensively below) may be key to 
at least revealing the dynamics and sequence of events in transcription, if not their causative 
roles, though achieving the resolution required to visualize transcriptional events in intact loci is 
an ongoing challenge38,85. 
De novo identification of genomic regions that serve as enhancers is an ongoing 
challenge. The gold standard, more practical now given the development of CRISPR, is enhancer 
deletion or mutation in cells or organisms and measurement of resulting alteration of target gene 
transcription (for example,70,86 ). However, this approach is relatively cumbersome and low-
throughput. The next best type of approach measures enhancer activity using a reporter system, 
a type of experiment that can be highly multiplexed87,88. However, there is some evidence that 
such assays may not always report faithfully on endogenous enhancer activity89. Approaches to 
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enhancer identification that don’t directly measure transcriptional activity are the least costly and 
most efficient, but any individual criterion to identify putative enhancer regions has not been 
perfectly reliable90: such approaches include identifying evolutionarily conserved distal regions, 
measuring transcription factor binding of one or multiple factors using ChIP, mapping locations of 
histone-3 lysine-27 acetylation, of histone-3 lysine-4 monomethylation, of DNAse-I 
hypersensitivity distal to transcription start sites, or of Pol II binding distal to transcription start 
sites, or measuring transcription of distal regions themselves using a method like PRO-seq 
(described below)66,91,92 . Hybrid approaches combine multiple of these markers and give more 
faithful information than any individual marker alone93; hopefully as data from genetic enhancer 
manipulation accumulates, such algorithms to identify enhancers will be optimized to help identify 
regulatory regions de novo in cell types and diseases of interest.  
 A great deal of enthusiasm in recent years has been devoted to the concept of 
‘superenhancers’: large enhancer regions that function as more than the sum of their constituent 
regions94–96. These regions were proposed to not only be more powerful than the sum of their 
constituent regions, or than shorter ‘typical’ enhancers, but were also thought to be more 
sensitive to perturbation, and additionally to be more likely to direct transcription of important cell-
identity genes like the transcription factors Myc (in several cell types) and Sox2 (in ES cells)96. 
This categorization of enhancers implied that enhancer length and histone-modification density 
should be able to predict enhancer strength. However, careful studies have suggested that the 
existence of a discrete superenhancer category with distinct properties from ‘typical’ enhancers 
perhaps was overstated and not a general rule97: two elegant studies in particular suggested that 
regions of an enhancer might contribute additively to the activity of the whole enhancer71,98.  
Beyond the identification of enhancers which can drive transcription, the field has also 
struggled to identify rules for how an active enhancer selects which target gene to activate. 
Indeed, the initial observation of enhancer activity showed that the SV40 large T antigen 
enhancer could drive the mammalian beta-globin gene, immediately showing that enhancers 
could display some degree of promiscuity62. In some cases, enhancers are exquisitely specific, 
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skipping intervening genes to activate a further away specific target gene. For example, a study 
shows that in embryonic stem (ES) cells, only 2/3 of active promoters genome-wide contact the 
nearest enhancer, while the other genes appear to be controlled by non-neighboring 
enhancers8,99. However, in most transgenic experiments, an enhancer is able to drive a wide 
variety of promoters87,100,101. One simple solution is that in some cases specificity does not seem 
to be critical to biological function: in some cases, enhancer deletion influences multiple genes in 
a region102,103. In a series of elegant high-throughput studies in Drosophila, it was shown that 
though enhancers were not absolutely specific, they had preferences for promoters of the same 
‘type’, i.e. housekeeping gene enhancers promoted the transcription of housekeeping gene 
promoters more strongly, while developmental gene enhancers promoted the transcription of 
developmental gene promoters most strongly88,104. To what extent this discovery of enhancer 
categories applies to mammals is as yet unclear. In some cases, genome organization seems to 
help promote enhancer target specificity: for example, the critical oncogene Myc, driven by 
different strong enhancers in different tissue types, sits in a relatively gene-poor region, perhaps 
to avoid inappropriate activation of the Myc gene, or of other genes by its enhancer63,64. Higher-
order chromatin structure such as the delimitation of so-called ‘topologically associating domains’ 
(TADs) is also important for ensuring enhancer fidelity in some cases105–108, as will be further 
discussed below. Heterochromatinization of stage-inappropriate genes may also prevent 
enhancer activation in some cases26. However, general mechanisms of enhancer specificity 
remain somewhat unclear: perhaps a combination of strong gene repression, and a robustness of 
cells to some inappropriate gene activation, is sufficient to explain how appropriate cell function is 
maintained without a high degree of intrinsic enhancer specificity. 
 
1.3a: The beta-globin locus control region 
One of the key model systems which has allowed a deeper understanding of 
transcriptional control by enhancers is the beta-globin locus in mammalian red blood cells. The 
mammalian beta-globin locus includes several developmentally regulated forms of beta-globin, 
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including embryonic, fetal, and adult forms, spread over around 100 kb109,110. All of these genes 
are regulated in their respective developmental stage by a large enhancer known as the beta-
globin locus control region. This region consists of 5 DNase-I hypersensitive sites, each with 
binding sites for different transcription factors111. In particular, GATA-1 and KLF-1 must bind the 
LCR and mediate clustering of the hypersensitive sites with the promoter in order to promote 
transcription of the stage-appropriate beta-globin gene52,81. Indeed, the Blobel lab showed that 
redirecting this enhancer complex to a developmentally-inappropriate globin gene is sufficient to 
activate that gene: specifically, they were able to increase transcription of the fetal form of beta-
globin in adult erythroid cells112. The LCR generally conforms to the additive model of enhancer 
function: deletion of each hypersensitive site reduces beta-globin transcription, and combined 
deletion of multiple HS sites has stronger effects than individual deletions113. The LCR may 
activate transcription of target genes via several mechanisms: deletion of parts of the LCR 
reduces PIC formation at the promoter, and also may impact promoter-proximal pause 
release72,73. The beta-globin locus has also been an interesting model of how an enhancer may 
drive transcription of multiple genes, and a number of studies have investigated whether the 
enhancer may drive transcription of multiple target genes simultaneously, or whether instead 
promoters compete for the activity of the LCR114,115. In my work, we took advantage of the 
previous thorough characterization of beta-globin locus regulation to investigate single-cell 
transcription and transcriptional bursting regulation in this system. 
 
1.4 Chromatin structure: higher-order organization in transcription 
 One of the main issues raised by the existence of distal regulatory regions is how a 
specific enhancer is coupled to its target promoter, and how it avoids spurious activation of other 
nearby genes. One possible solution to this is specific promoter-enhancer looping, discussed 
above. Another hypothesis is that higher-order conformation of genomic DNA in the nucleus 
helps govern transcriptional fidelity. Historically, the study of DNA organization in the nucleus 
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began with imaging studies such as the first images of chromosomes performed by Boveri, 
leading to studies asking whether there were specific regions for each chromosome, or territories, 
in the nucleus105,116,117. Indeed, genomic regions are much more likely to contact regions within 
their own chromosome than between chromosomes, and there is evidence for some selective 
radial positioning of chromosomes, though chromosome locations are not identical in each cell 
nucleus and may change after a cell divides118.  
The finding of chromosome territories may explain the limitation of enhancer activity to its 
own chromosome; however, if genomic structure governs enhancer action, then finer layers of 
nuclear structure must be responsible to avoid spurious activation of genes nearby on the same 
chromosome. The local ‘domain’ structure of genomic DNA has been enthusiastically studied for 
the past ten years, especially after the advent of high-throughput chromosome conformation 
capture techniques78. Such methods employ formaldehyde crosslinking to capture physical 
contacts between linearly distal regions of DNA; high-throughput versions of these methods, such 
as Hi-C, enable more unbiased analysis of contacts without requiring selection of a single 
candidate region of interest78,119 . Lieberman-Aiden et al. used genome-wide chromosome 
conformation capture to show that the nucleus is partitioned into active (‘A’) and repressed (‘B’) 
domains, and that genomic regions tend to clump like with like78. This ‘compartment’ structure of 
chromosomes in the nucleus may help avoid spurious activation of repressed domains, and may 
help ensure that even if enhancers act somewhat promiscuously on multiple genes, the other 
physically proximate regions are already being actively transcribed rather than suppressed. This 
compartmental clustering of active and of inactive regions has been validated directly by 
imaging120. Moreover, inactive domains are more likely to be excluded from the center of the 
nucleus and instead pushed to the lamina121. This laminar localization can directly disfavor 
transcription in some cases122. However, elegant single cell studies showed that localization to 
the nuclear lamina is non-deterministic, meaning that a lamina-associated region in one cell may 
shift away from the lamina when the cell undergoes division or vice versa123 Thus, evidence 
suggests that compartment structure may help confine enhancer activity to active genes on the 
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same chromosome, but that such compartmentalization is not absolutely deterministic and can 
vary cell to cell. 
A further level of organization thought to promote specificity of transcriptional regulation 
are TADs or topologically associating domains, first characterized in 2012 by several 
groups105,106,124. Satisfyingly, the existence of TADs was more recently confirmed by two 
orthogonal experimental approaches120,125. These regions average around 1 megabase, although 
different groups have used different algorithms to identify them and thus TAD sizes and locations 
vary between publications126. In general, however, TADs are computationally and functionally 
defined as genomic regions which interact more strongly within themselves than with regions 
outside their boundaries105,106,124. Many TADs have binding sites for CTCF, a protein first 
characterized as an ‘enhancer insulator’, at their boundaries, and these CTCF sites are typically 
convergently oriented126,127. CTCF has been shown to form homodimers, and thus such 
convergent binding sites are thought to mediate interactions between CTCF molecules sitting at 
the base of TAD loops 126. It is hypothesized that DNA loop extrusion by the cohesin complex, 
proceeding from the center of TADs until cohesin is blocked by CTCF at the base of each TAD 
loop, establishes and maintains TADs as domains separated from each other128–130. Enhancers 
typically tend not to activate genes outside their TAD108. Moreover, TAD boundaries are relatively 
conserved compared to other intergenic regions, both between different cell types in the same 
organism, and across different mammalian species, and even appear to be somewhat consistent 
in single cells129,131,132. In some cases, mutation of TAD boundaries can lead to mis-activation of 
genes by enhancers from the neighboring TAD, as such a model would predict107,133. Moreover, 
global genome methylation in cancer cells led to enhancer-promoter miswiring in one cell system, 
which the authors suggested was due to the inability of CTCF to bind methylated chromatin134. 
However, in some cases, TAD boundary mutation has negligible effects on transcription135. 
Moreover, transient depletion of CTCF from cells, which dissolves the structure of most TADs, 
has moderate or negligible effects on transcription, depending on the system used136,137. (Note 
that permanent CTCF depletion is toxic for cells, so transient studies were critical to explore the 
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function of CTCF in transcription.) Given these equivocal results, it is likely that TADs may not be 
as critical for governing transcription as the earliest studies may have suggested. In future, 
imaging of TADs in single cells coupled with single cell transcriptional measurements may clarify 
to what extent TADs govern localization and transcription of genes within them. 
 
1.5 The mechanics of transcription: initiation  
 Once a gene has the potential to transcribe due to transcription factor binding at its 
enhancer and promoter and recruitment of activating factors, the mechanics of transcription itself 
come into play. The polymerase initiation complex (PIC) must be assembled at the transcription 
start site, recruited to the degenerate promoter sequences described above58,60 . The mammalian 
PIC consists of more than 40 proteins, including notably TFIIB, C, D, E, F, and H, which 
assemble in a stereotyped sequence and conformation138–141. For example, the TFIID complex 
directly recognizes the TATA box and other promoter motifs and binds DNA, and serves to 
nucleate the assembly of the other factors on DNA139,142. These other proteins act both to unwind 
the DNA at the promoter, a step which specifically requires the helicase activity of TFIIH139,143, 
and to bring Pol II itself to the beginning of the gene. PIC assembly and unwinding of promoter 
DNA has been suggested to be a rate-limiting regulated step in eukaryotic transcription139,144 . 
 Structural studies of the initiation complex have helped reveal the steps involved in PIC 
formation. The large size and numerous components of the PIC historically made it extremely 
challenging to crystallize using conventional methods141,145. However, the development of the 
cryo-EM technique, which applies a newly-developed high-resolution camera and computational 
alignment techniques to identify structural conformation of large multiprotein complexes to several 
angstrom resolution, has been valuable in clarifying the sequence of events involved in PIC 
assembly141,145. While conventional protein crystallization yields a single crystal structure, the 
cryo-EM technique averages together images of individual complexes: therefore, if the complex 
exists in several different conformational states, a single cryo-EM experiment can yield 
16 
 
information on all of these states, which has proved valuable in studying PIC assembly141,145. For 
example, the Nogales group found that TFIID, the factor which directly binds the TATA box of a 
promoter, mediates a sharp bend in promoter DNA when it binds, while the TFIIH complex which 
helps melt the promoter DNA to allow RNA transcription also changes conformation upon binding 
to the promoter146–148. Ultimately, such studies will continue to give us a better understanding of 
the dynamics and steps of transcriptional initiation.  
 
1.6 The mechanics of transcription: promoter-proximal pause release 
 In bacteria, polymerase recruitment is the main checkpoint governing transcriptional 
activation of a gene, and initially this was assumed to be true of eukaryotic genes4. However, 
more recently a second major checkpoint controlling the rate of RNA production by Pol II was 
identified by the Lis lab and others: promoter-proximal pausing61,149 . In this process, Pol II is 
stalled approximately 30 to 50 base pairs downstream of the transcriptional start site149. Elegant 
experiments blocking initiation and measuring the half-life of paused Pol II complexes have 
showed that such paused complexes can be quite stable, in the range of minutes to tens of 
minutes150. In order for polymerase to transcribe full-length RNA, the pTEF-b kinase complex, 
made up of cyclin T1 and CDK9 proteins, must phosphorylate the C-terminal domain of Pol II as 
well as negative elongation factors149. Indeed, direct tethering of pTEF-b in a Drosophila system 
is sufficient to drive transcription of heat shock genes in the absence of stimulus, demonstrating 
that this complex is key to the pause release process151. However, other proteins including BRD4 
and the super-elongation complex also can collaborate in the pause release process152,153. 
Promoter-proximal pause release is globally required at all genes in higher eukaryotes, because 
pharmacological blockade of pTEF-b globally arrests transcription150,154 . The degree of pausing 
at different genes is governed by the promoter elements of that gene155. It remains unclear 
exactly how the rate of pause release is regulated: there must be some gene-specific element to 
this regulation, because certain genes are maintained in the paused state without transcription 
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(for example heat shock genes in Drosophila), while other genes in the same cells undergo 
elongation. In future, live imaging approaches of RNA transcription and of proteins involved in 
pause release perhaps can be applied to help clarify the dynamics and regulation of this process. 
 
Figure 1.2: Experimental methods used to measure transcription. A) Biochemical population-
averaging techniques discussed in section 1.6. B) Imaging-based techniques discussed in section 1.7. 
 Though often polymerase initiation and pause release are considered as independent 
and sequential processes, recent evidence demonstrates that they are interrelated. Specifically, 
the very size of the PIC means that if a polymerase complex is paused in the promoter-proximal 
region of a specific gene copy, no second polymerase molecule is able to initiate at the promoter 
until the first pause polymerase has moved into the gene body156,157. This cross-inhibition of 
initiation and pausing is a critical consideration when modeling the process of transcription in 
higher eukaryotes. Promoter-proximal pausing has also been suggested to be a mechanism by 
which genes can be quickly activated upon stimulus149, however, since only 2-4 molecules of 
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RNA could be generated per cell by such an approach without further transcriptional initiation 
(depending on the cell cycle status of the cell in question), we suggest that it seems unlikely that 
this mechanism is as quantitatively essential as some have suggested. 
 Biochemical approaches have been used extensively to measure nascent transcription, 
and the choice of technique in large part should be dictated by the experimental question at issue 
(Figure 1.2). The most straightforward approach is total RNA sequencing (since poly-A selection 
will omit most nascent RNA species): the abundance of intronic sequences, which are degraded 
soon after transcription, can serve as a proxy for active transcription158. However this approach is 
needlessly costly since the majority of species sequenced are mature RNA. Thus, methods to 
enrich for nascent RNA can be more practical in measuring nascent transcription. Such 
enrichment approaches include TT-seq, which allows cells to transcribe briefly in the presence of 
4-thiouridine: incorporation of this nucleotide allows biochemical enrichment and sequencing of 
recently transcribed RNAs159. GRO-seq and PRO-seq are other techniques that allow 
biochemical enrichment and sequencing of nascent RNAs61,149,160. PRO-seq and GRO-seq, like 
TT-seq, provide high-resolution information about nascent transcription, which can be critical to 
identify precise transcriptional start sites, and to provide directional information about transcription 
such as in cases of divergent transcription149. A downside of the PRO-seq/GRO-seq techniques 
is that they require transcription to take place in isolated nuclei after the addition of the detergent 
sarkosyl, which might bias results due to the nonphysiological conditions. A final type of approach 
uses chromatin immunoprecipitation to enrich for Pol II, either to measure Pol II binding as a 
proxy of transcription, or to purify Pol II associated RNAs and perform RNA sequencing (NET-
seq)161,162. This approach is lower-resolution than PRO-seq/GRO-seq, not allowing nucleotide-
level information of how much a region has been transcribed, but allows transcription to occur in 
situ in unmanipulated intact cells, and thus may provide the most physiological record of nascent 
transcription. Thus, choice of biochemical technique to measure transcription should be dictated 
by experimental question. Most of these approaches can help measure promoter-proximal 
pausing, with slight variations in the analysis method: the short nascent RNAs transcribed before 
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pausing are quite unstable and very short, so total RNA-sequencing is not a good approach for 
this sort of question. PRO-seq and GRO-seq reveal Pol II that is ‘transcriptionally engaged’ even 
if the RNA is unstable, so pausing will produce a strong promoter-proximal signal in these 
techniques149. Similarly, Pol II ChIP-seq will reveal a strong peak of Pol II if many cells contain 
paused Pol II near the promoter 149. Note that the presence of these pause Pol II signals will be 
influenced by both the number of cells with paused Pol II, and by the average duration of time 
that polymerase remains paused without undergoing elongation at that gene. All such techniques 
average the transcriptional behavior of many cells, and this should be kept in mind while creating 
models based on such data. 
 
1.7 Transcription in single cells: transcriptional bursting 
 The biochemical approaches to measuring nascent transcription described above have 
been extremely powerful; however, the advent of imaging studies of nascent transcription 
revealed that some of the complexity of transcription had been occluded by the population-based 
nature of such assays. First, it was observed that cells containing mRNA for highly expressed 
genes did not display active transcription of those genes at all times163–165. Moreover, the 
distribution of mRNAs for a given gene in a population of cells could not be fit by a Poisson 
distribution: this observation suggested that RNA transcription was likely to happen in ‘bursts’ of 
multiple RNAs, and there must be a step upstream of transcription that altered the likelihood of 
RNA production over time166,167. (This distributional argument could be compared to recording the 
number of cars on a stretch of rural highway- with no traffic control, cars are distributed in a 
roughly Poissonian manner- compared to recording the number of cars on a city street- in the 
latter case, clusters of cars are likely to appear, and thus one could infer the presence of a 
stoplight controlling traffic flow even if one couldn’t see the stoplight itself. RNA patterns adhered 
to the latter pattern rather than the former.) Moreover, transcriptional bursting was found to be 
stochastic in the sense that different alleles in the same cell transcribed in an independent and 
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uncoupled manner164,168,169. These initial studies were performed with the single-molecule RNA 
fluorescence in-situ hybridization (FISH) technique (Figure 1.2)163,170 ,which uses multiple 
fluorescently labeled DNA oligonucleotides to hybridize to RNAs of interest and allow direct 
quantitation of RNA counts in single cells. Since the initial observation of bursting in fixed cells 
described above, the RNA FISH technique has been applied to a wide variety of genes, 
organisms, and cell types, demonstrating that transcriptional bursting is an apparently universal 
property of transcription in higher eukaryotes, including in mammalian tissues169,171,172.  
 Direct confirmation of this transcriptional bursting phenomenon was enabled by the 
development of the MS2 stem loop system to label nascent RNA in live cells 173,174. This 
approach uses overexpression of a bacteriophage coat protein fused to a fluorescent protein 
such as GFP in cells or animals; this overexpressed protein binds the stem-loop RNA structure 
originally found in the bacteriophage, so that knocking 12 or 24 repeats of this stem-loop 
sequence into an RNA of interest creates an intense fluorescent signal wherever this RNA 
species is present in a cell.  This MS2 approach revealed that transcription was discontinuous 
through time in Drosophila embryos and mammalian cells, as well as in primary mouse 
cells172,175. Moreover, by applying stimuli to cells and measuring nascent transcription with either 
live or fixed methods, it became clear that properties of these transcriptional bursts could be 
regulated176,177.  
 Since the studies mentioned above directly measured RNA production but were unable to 
visualize protein regulators of this process, mathematical modeling has been applied extensively 
to such datasets to try to infer the regulation of transcriptional bursting. The most commonly used 
model, which fits the data well in many cases, is the so-called random telegraph model163,178,179 : 
this model suggests that two rates regulate a gene’s transcriptional output, the rate of ‘burst 
initiation’ which controls the frequency of transcriptional bursts, and the rate of ‘RNA production’, 
perhaps related to polymerase initiation, which controls the number of RNAs produced per burst, 
or the ’burst intensity’. Some live-imaging studies have found evidence for a third regulated rate, 
upstream of burst initiation, which can produce a so-called refractory period, meaning that there 
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tends to be a period of transcriptional silence between bursts180,181. Other studies have suggested 
yet more complex regulatory architectures, such as one which suggested there are many (more 
than 5) major regulated rates governing transcriptional bursting182. However, it is still unclear how 
these mathematically inferred regulated steps relate to actual molecular regulators of 
transcription, such as those described in previous sections. 
 Most promisingly, in recent years studies have started to apply super-resolution imaging 
approaches to visualize transcription in tandem with proteins that regulate transcription to clarify 
the regulation of the dynamics of transcription37,183. For example, the Cisse group has devised an 
approach to visualize Pol II molecules simultaneously with live imaging of a gene of interest. This 
approach revealed that Pol II clusters around a promoter just before a burst of transcription 
starts38. This clustering behavior has been used to support a model that Pol II is undergoing 
condensation or phase separation at the promoter to drive transcription18,184 , however it is difficult 
to directly assay the physical properties of Pol II in such a system, or to examine the necessity of 
this type of condensation to drive transcription. In another multicolor live imaging approach, the 
Gregor group established a system to enable enhancer and promoter conformation imaging along 
with live imaging of transcription85 (discussed further in the Discussion). In future, it will be 
valuable to visualize more protein players in such a system, perhaps including p-TEFb or the 
polymerase initiation complex components, to learn more about the dynamics of transcription. 
Perhaps such a system could be paired with drug-induced degradation approaches136,137 to 
enable causal dissection of the events taking place during transcription in live cells. Moreover, a 
consistent difficulty in such studies has been the cumbersome genetic engineering required to 
allow both single protein molecules and nascent RNA to be visualized. CRISPR has helped 
ameliorate both these difficulties somewhat by making it easier to knock in stem-loops or tag 
sequences, however still only a limited number of genes and cell systems has been used for live 
imaging, potentially limiting the generalizability of the findings above.  In future, it is likely that 
imaging techniques using Cas9 or other bacterial Cas proteins to bind RNA and DNA may be 
optimized, allowing wider application of such techniques185,186.  
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1.8: Perspective on the field of transcriptional regulation 
 Transcriptional regulation is one of the key processes that allow cells to change or to 
maintain their functional state. A number of themes have emerged from the sixty or more years of 
study devoted to this topic. First, transcriptional regulation in mammals is complex: many 
molecular players and steps are required for transcription of any given gene. Moreover, simple 
and elegant rules do not always generalize easily between different genes and contexts, as 
demonstrated for example by the ongoing difficulties in computational prediction of enhancer 
function. In spite of this complexity, some general patterns have emerged, such as the 
requirement for PIC assembly and promoter-proximal pause release for RNA production to occur, 
as well as the generality of the transcriptional bursting phenomenon. Relatedly, the field has 
benefited from the development and application of multiple orthogonal experimental techniques to 
measure transcription and transcriptional regulation: for example, the development of RNA 
imaging techniques revealed transcriptional bursting behavior that was invisible by bulk 
biochemical techniques. High-resolution imaging allowing tracking of multiple protein, DNA and 
RNA components in live cells are becoming more accessible and hopefully will help deepen 
understanding of the dynamics and spatial characteristics of transcription in single cells 38,187,188. 
Such studies should be coupled with targeted perturbations, to allow dissection of causative 
relationships in transcription. A general technical challenge in this field (as well as many other 
biological questions) is the candidate-based nature of protein measurements: for example, ChIP-
based studies require antibodies, while imaging approaches require engineering of specific 
proteins. Perhaps in future, more sensitive unbiased approaches such as locus pulldown189 single 
cell mass spectrometry190, or antibody-free binding protein design191 might allow unbiased 
identification and functional dissection of proteins involved in the different steps of transcriptional 
regulation. More conceptually, the field has now identified many of the players in transcriptional 
regulation: the next step, difficult so far, is to integrate these pieces of information to predict 
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transcriptional outcomes in a cell type or organism28,93,192,193. It is not clear how the newest 
concepts in the field which generate the most excitement, such as superenhancers or phase 
separation, will help us advance toward this goal of prediction. Rather, such topics of research 
seem to propose alternate mechanisms for transcriptional behaviors for which we already have 
explanations (incomplete though these explanations may be). It will be exciting to watch the field 
hopefully develop better predictive models for how the complexities of eukaryotic development 
are orchestrated in time and space. 
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CHAPTER 2: Enhancer regulation of transcriptional bursting parameters revealed by 
forced chromatin looping 
2.1 Introduction 
 
Transcription of most genes in mammalian cells occurs in bursts interspersed with 
refractory periods of varying lengths, both in cell lines and in tissues 163,164,167,171,173,181,183,194,195 . 
Transcription of a given gene can be increased through modulation of several different burst 
parameters. For instance, the gene could increase in burst fraction (the number of alleles 
transcribing per cell, which is related to how frequently bursts occur), or burst size (the number of 
RNA molecules produced per burst). For example, serum-induced transcription activation of b-actin 
augments both burst frequency and burst size, while serum induction of c-Fos leads to an increase 
in burst frequency without changing burst size176,177. Recent evidence further suggests that 
maintenance of mRNA concentrations in response to changes in cell size are achieved through 
changes in burst size, while gene dosage compensation in the cell cycle is regulated by burst 
frequencies196.  However, the molecular regulation of transcriptional bursts remains unclear.   
Enhancers are distal genetic elements that regulate transcription of their target genes by 
diverse modes, which include altering chromatin structure and histone modifications, recruiting 
basal transcription factors, localizing genes to permissive nuclear compartments, or increasing 
transcriptional elongation8,66 . However, most studies on enhancer function are population based, 
leaving open how enhancers affect transcription dynamics at individual alleles. 
The b-globin locus control region (LCR) is a powerful distal enhancer that is required for 
high level transcription of all b-type globin genes197–199. The LCR engages the embryonic (e-globin), 
fetal (g-globin), and adult type (b-globin) globin genes through looped contacts in a developmentally 
appropriate manner76,77,200. Proposed mechanisms by which the LCR activates transcription include 
recruiting tissue-specific and general transcription factors as well as RNA polymerase II, moving 
the locus towards the center of the nucleus and outside the chromosome territory, as well as 
promoting transcription elongation72,113,198. How these mechanisms impact transcriptional burst size 
25 
 
versus fraction is unresolved. A related open question is how the LCR controls bursting in the 
context of multiple active or potentially active b-type globin genes within the locus. 
A landmark study using RNA FISH demonstrated that at a fraction of alleles g-globin and 
b-globin located on the same chromosome can be transcribed during the same developmental 
stage114. This study further provided evidence that the appearance of allelic co-expression of g-
globin and b-globin results from rapidly alternating interactions of these genes with the LCR. 
Subsequent studies that included kinetic experiments provided additional support for the idea that 
LCR-promoter contacts are so dynamic that the appearance of allelic co-transcription is actually 
the result of very rapid transcriptional switches115,201,202. A model in which only one promoter 
interacts with the LCR at any given time would also explain competition among the genes. 
However, none of these studies excluded the possibility that the LCR acts on both genes 
simultaneously. Besides simultaneous LCR-gene contacts, an additional scenario compatible with 
allelic co-expression is that one gene could be transcribed dependently and the other independently 
of the LCR. Indeed, the b-type globin genes are transcribed in the absence of the LCR albeit at 
much lower levels197. The application of quantitative RNA FISH to examine transcriptional bursting 
parameters might allow discrimination between these models.  
 Here, we used quantitative single-molecule RNA FISH170,203  to measure transcriptional 
burst size and burst fraction of the b-globin gene during erythroid maturation. We observed 
increases in both transcriptional burst fraction and size during this process. The enhancing effects 
of the LCR on b-globin transcription are predominantly explained by augmenting burst fraction with 
a modest but significant contribution to burst size, as revealed by LCR deletion experiments. To 
study the relationship between LCR-promoter contact frequencies on bursting parameters we 
applied a forced chromatin looping system. Specifically, forced tethering of the nuclear factor Ldb1 
via designer zinc fingers to a chosen b-type globin gene promoter leads to recruitment of the LCR 
and transcription activation79,112. We found that in murine erythroblasts, engagement of the LCR 
increased b-globin burst frequency but not burst size. Similarly, in primary adult human erythroid 
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cells, redirecting the LCR towards the g-globin genes and away from b-globin genes increased g-
globin burst fraction while lowering b-globin burst fraction. A significant proportion of alleles co-
transcribed b- and g-globin, but allelic co-transcription of b- and g-globin was statistically disfavored. 
Strikingly, the burst size of co-transcribed genes is not reduced compared to singly transcribing 
genes, further supporting the model that promoters compete for LCR activity and that LCR-
promoter looping controls burst fraction. In concert, these results provide new insights into 
mechanisms of enhancer function and highlight the use of targeted alterations of chromatin 
architecture for functional studies of enhancers. 
 
2.2 b-globin transcriptional burst fraction and burst size increase during erythroid 
maturation 
 
An increase in transcription at a given allele can occur through elevated burst fraction, burst 
size or a combination of both (Figure 2.1A). We first measured b-globin transcriptional bursting 
parameters in the G1E-ER4 murine erythroblast cell line during the course of erythroid maturation, 
when b-globin transcription is strongly induced. Maturation of these cells is dependent on the 
hematopoietic transcription factor GATA1, which is expressed in these cells as an estrogen 
receptor fusion protein. Addition of estradiol triggers erythroid maturation and increases contacts 
between the LCR and the b-globin promoter, faithfully reproducing normal terminal erythroid 
maturation49,50,52. We measured transcription of the adult b-globin (Hbb-b1) gene at different time 
points during G1E-ER4 maturation using single-molecule RNA FISH170,203. Transcription sites were 
identified by nuclear colocalization of spectrally distinguishable signals from probes specific for b-
globin introns and exons (Figure 2.1B)168.  
We verified that transcription sites faithfully reported recent transcriptional events by 
blocking transcription with actinomycin D and counting b-globin transcription sites in human 
erythroid cells (Figure A2.1A). This control showed that 90% of transcription sites were lost at 30 
minutes post-drug treatment, and half disappeared by just 10 minutes, validating that our 
transcription site identification faithfully reported ongoing transcription. 
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Both burst fraction and average burst size increased during differentiation (Figure 2.1B-E, 
Figure A2.6), indicating that both parameters contribute to total b-globin production during cell 
maturation. Specifically, the increase in burst fraction from 4 to 24 hours of maturation was 3.4 fold, 
while the change in burst size from 4 to 24 hours was 1.8 fold (Figure 2.1D-E). The burst fraction 
increase corresponded to an increase in the proportion of cells transcribing 1,2, or 3 active b-globin 
alleles (Figure A2.1C). The overall increase in transcriptional output was consistent with the profile 
of RNA polymerase II (Pol II) binding at the b-globin locus, as determined by chromatin 
immunoprecipitation (ChIP) (Figure 2.1F). Moreover, we observed an increase in the fraction of Pol 
II in the gene body relative to the promoter (Figure 2.1G), reflecting an increase in elongating Pol 
II, consistent with the observed increases in burst fraction and size. To address possible variabilities 
in fluorescence intensities between slides and experiments we concurrently measured cyclin A2 
mRNA in the experiments shown in 1B-1E (Figure A2.1B). We found that cyclin A2 mRNA 
intensities were consistent between experiments. The subtle downward trend in cyclin A2 signal 
during erythroid maturation is opposite to that of the b-globin transcription sites (Figure 2.1E), such 
that normalization of β -globin bursting size to cyclin A2 would result in slightly larger changes 
during maturation. 
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Figure 2. 1: b-globin transcriptional burst fraction and burst size increase during erythroid 
maturation. A) Simplified model of how bursts can be modulated during murine erythroid maturation to 
increase b-globin mRNA levels. B) Single-molecule RNA FISH using b-globin intron and exon probes to 
identify transcription sites in G1E-ER4 cells, 4 or 24 hours after estradiol addition (white arrows indicate 
transcription sites, intron and exon channels are set to same intensities across images). C) Representative 
experiment showing fluorescence intensities of β-globin transcription sites in G1E-ER4 cells at indicated time 
points after estradiol addition (tics on x axis=medians for this experiment). D) Mean number of alleles 
transcribing β-globin per cell at time points after estradiol addition. N=3 biological replicates. E) Median 
fluorescence intensities of β-globin transcription sites in G1E-ER4 cells following estradiol addition. N=3 
biological replicates. F) Anti-RNA polymerase II ChIP in G1E-ER4 cells at indicated times after estradiol 
addition in the globin locus normalized to input. Primer pairs targeting distinct regions of the gene are listed 
on the x-axis. The silent CD4 locus served as a negative control. N=3 biological replicates. G) Ratio of RNA 
polymerase II ChIP signal at β-globin exon 2 to β-globin promoter. N=3 biological replicates.  Error bars 
represent SEM. See also Figures A2.1 and A2.6. 
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One question raised by this analysis is whether the variation in burst size might be strongly 
regulated by global transcriptional differences between cells (‘extrinsic noise’)204, as opposed to 
allele-level differences (‘intrinsic noise’). If, for example, transcription factor concentrations between 
cells varied widely, and if this variation were to determine differences in burst size, then two alleles 
bursting in the same cell should tend to have similar burst sizes. To quantify the contribution of 
extrinsic noise to burst size, we measured whether the sizes of bursts were correlated in cells that 
displayed two transcriptional bursts at various stages of maturation. We found that the correlation 
was not strong (maximum R2=0.293) and therefore differences between cells do not strongly 
determine individual burst sizes as measured by RNA FISH (Figure A2.1D-F). The correlation was 
slightly weaker at 9 hours of maturation compared to later time points, suggesting that cell-to-cell 
variability may play a slightly larger role in determining burst size variation later in differentiation. 
We note however that staggered initiation timing of bursts, as well as technical noise, can contribute 
to apparent intrinsic noise in this system. 
To test whether global changes during erythroid maturation might nonspecifically alter the 
measurements of bursting parameters, we examined transcription of Gata2, a gene that is active 
in erythroid precursors but silenced during maturation205. We found that the burst size and burst 
fraction of Gata2 are both reduced during maturation, suggesting that both parameters are 
regulated in a gene-specific manner (Figure A2.2). 
In sum, b-globin burst fraction and burst size increase during erythroid maturation. This 
finding raises the question of how these bursting parameters are governed, and whether burst 
fraction and burst size are governed independently of each other. 
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Figure 2. 2: Deletion of the LCR predominantly impairs β-globin burst fraction. A) GATA1 
ChIP-Seq browser track view of the b-globin locus. Peaks demarcate the b-globin promoter and DNase I 
hypersensitive sites of the LCR.  Guide RNA placements for Cas9-mediated LCR deletions are indicated. B) 
Single-molecule RNA FISH using b-globin intron and exon probes to identify transcription sites in wild-type 
and LCR-deleted G1E-ER4 cells 24 hours after estradiol addition (white arrows indicate transcription sites, 
intron channel is set to same intensities across images). C) Mean number of alleles transcribing β-globin per 
cell in G1E-ER4 wild-type and LCR-deleted cells, treated with estradiol for 24 hours. N=3 biological replicates. 
D) Fluorescence intensity of β-globin transcription sites in G1E-ER4 parental and LCR-deleted cells, exposed 
to estradiol for 24 hours. Wilcoxon non-parametric t-test, pooling the two LCR-edited clones, p=1.54e-10. Data 
from 3 biological replicates pooled. Error bars represent SEM. See also Figures A2.2 and A2.7. 
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2.3 Enhancer deletion by genome editing decreases β-globin burst fraction and size 
 
 Relatively little is known about the molecular control of bursting parameters. In particular, 
it is unknown how distal regulatory elements influence burst fraction and burst size. Previous 
studies that the LCR influences both burst fraction and size113. To quantify the contributions of the 
LCR to these parameters via single molecule RNA FISH, we generated two distinct G1E-ER4 cell 
lines with homozygous deletions of the LCR using different guide RNA pairs (Figure 2.2A, Figure 
A2.3A-G). Cells were induced with estradiol for 24 hours to examine the effect of the LCR in its 
most active state. The b-globin burst fraction LCR deleted cells is greatly reduced (311-fold and 
194-fold in line 1 and line 2, respectively, Figure 2.2B-C, Figure A2.7) when compared to control 
cells. For measurements of burst size we had to examine a large number of cells (8216 cells total 
between all conditions and replicates) given the strong reduction in burst frequencies in cells 
lacking the LCR. Moreover, we pooled across biological replicates and both clones in order to gain 
the number of transcription sites necessary to make a statistical comparison of burst size. Burst 
size was reduced approximately 3-fold in cells lacking the LCR- compared to parental G1E-ER4 
cells (3-fold for each clone, Figure 2.2B and 2.2D). We note that we measured an equal number of 
transcription sites from each clone, and the means of both populations were the similar, justifying 
the pooling the two clones in the final analysis. These results suggest that the LCR predominantly 
controls burst fraction with a lesser but significant impact on burst size. 
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Figure 2. 3 Forcing LCR-promoter contacts increases β-globin burst fraction independent 
of burst size. A) Schematic of the forced looping strategy in murine G1E cells lacking GATA1. B) Mean 
number of alleles transcribing β-globin per cell infected with empty vector or vector expressing mZF-SA. N=3 
biological replicates. C) Fluorescence intensity of β-globin transcription sites. Wilcoxon non-parametric test 
comparing control and mZF-SA intensities, p=0.42. Data were pooled from 3 biological replicates. D) 
Schematic of the forced looping strategy in murine G1E-ER4 cells induced for 9 hours with estradiol. E) Mean 
number of alleles transcribing β-globin per cell in G1E-ER4 cells infected either with control vector or mZF-
SA, 9 hours after estradiol addition. N=3 biological replicates. F) Representative experiment showing 
fluorescence intensity of β-globin transcription sites in G1E-ER4 cells, infected either with control vector or 
vector expressing mZF-SA, 9 hours after estradiol addition. G) Median fluorescence intensity of β-globin 
transcription sites in G1E-ER4 cells infected either with control vector or mZF-SA, 9 hours after estradiol 
addition. N=3 biological replicates. Error bars represent SEM. See also Figures A2.3 and A2.8. 
 
33 
 
2.4 Forced enhancer-promoter contacts increase b-globin transcriptional burst fraction 
but not burst size 
 
The LCR forms looped contacts with the promoters it regulates. Since the LCR influences 
both burst fraction and size, we set out to test whether these two effects are both controlled by 
LCR-promoter contact frequencies or whether they are mechanistically separable. We used a 
recently developed strategy to force LCR-promoter contacts that involves tethering of the self-
association domain (SA) of nuclear factor Ldb1 by a designer zinc finger (ZF) to the b-globin gene 
promoter, which leads to recruitment of the LCR and transcription activation (Figure 2.3A)79. The 
unique advantage of this system is that it allows targeted formation of enhancer-promoter contacts 
without otherwise perturbing the locus or cell state. G1E cells lack GATA1 and as a result have few 
if any LCR-promoter contacts. G1E cells expressing a ZF-SA fusion protein specific for the murine 
b-globin promoter (mZF-SA) exhibit LCR-promoter contact frequencies approximating those of 
GATA1 replete cells. We infected G1E cells with a control retroviral vector or a derivative 
expressing mZF-SA as part of an IRES-GFP construct, followed by fluorescence-activated cell 
sorting (FACS) to enrich for infected cell populations. Increasing LCR-promoter contacts by mZF-
SA significantly increased b-globin burst fraction compared to controls (Figure 2.3B, Figure A2.8). 
Surprisingly, burst size was unchanged by mZF-SA expression (Figure 2.3C). 
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Figure 2. 4 Effects of maturation and forced LCR-promoter contacts on transcriptional 
bursting parameters in human erythroid cells. A) Mean number of alleles transcribing β-globin per 
cell, and B) median fluorescence intensity of β-globin transcription sites at 0 or 3 days of maturation induction. 
N=3 human donors. C) Schematic of forced LCR-γ-globin promoter loop strategy in primary human erythroid 
cells. D) Single-molecule RNA FISH of g- and β-globin in human primary erythroid cells infected with hZF-SA 
expressing vector or control vector. E) Mean number of alleles transcribing g-globin per cell in hZF-SA 
expressing cells or control cells, normalized to proportion transcribing in the control vector condition. Wilcoxon 
paired t-test, p=0.016. N=5 human donors. F) Mean number of alleles transcribing β-globin per cell normalized 
to control vector condition. Wilcoxon paired t-test, p=0.42, or p=0.2 excluding outlier. N=5 human donors. G) 
Median fluorescence intensities of -globin transcription sites cells infected with control vector or hZF-SA vector, 
normalized to proportion transcribing in the control vector condition.  Wilcoxon paired t-test, p=0.84. N=5 
human donors. H) Median fluorescence intensities of β-globin transcription sites in cells infected with control 
vector or hZF-SA vector, normalized to proportion transcribing in the control vector condition.  Wilcoxon paired 
t-aest, p=0.09. N=5 human donors. Error bars represent SEM. See also Figures A2.4 and A2.9. 
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Since the LCR contains numerous GATA1 binding sites, its activity in G1E cells is 
compromised. Therefore, we carried out similar experiments under conditions in which GATA1 
activity was partially restored. We retrovirally introduced mZF-SA and control constructs into G1E-
ER4 cells and exposed them to estradiol for 9 hours, which results in partial differentiation and 
activation of b-globin transcription (Figure 2.3D). Similar to in the G1E system, mZF-SA increased 
b-globin burst fraction, but did not alter burst size (Figure 2.3E-G). b-globin transcription was 
confirmed to be increased by qPCR (Figure A2.4A). Together these results suggest that enhancer-
promoter contacts augment the likelihood for a burst to occur, but that they do not determine burst 
size. The use of the mZF-SA reagent thus enabled the uncoupling of enhancer looping from other 
potential enhancer functions that might impact on the b-globin locus. 
2.5 b-globin transcriptional burst fraction and size increase during human erythroid 
maturation 
 
In order to investigate whether the regulation of b-globin transcriptional bursting during 
erythroid maturation is conserved between mice and humans, we examined primary human 
erythroblasts. Human CD34+ hematopoietic precursors from peripheral blood were expanded and 
differentiated towards the erythroid lineage using a previously described two-phase liquid culture 
system206. We measured adult type b-globin (HBB) burst size and fraction before and after 3 days 
of erythroid differentiation induction. During this process we observed an increase in both burst size 
and fraction of the b-globin gene, similar to our observations in maturing murine erythroid cells 
(Figure 2.4A-B). The increases in burst fraction (1.7 fold) and average burst size (1.6 fold) are 
comparable in magnitude and thus are both likely to contribute to increased b-globin production 
during erythroid maturation.  
 
2.6 Forced switching of enhancer contacts between two promoters reciprocally alters 
burst fraction 
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To examine whether the human LCR regulates bursting in the same manner as the murine 
LCR, we employed a forced looping strategy (Figure 2.4C)112. The human b-globin locus spans 
several globin genes, including the adult type b-globin and a fetal form called g-globin (HBG). We 
reported previously that expression of a ZF-SA construct targeting the g-globin promoter (hZF-SA) 
in human primary erythroid cells increased LCR contacts with the g-globin gene at the expense of 
the b-globin gene with corresponding changes in transcription, consistent with a mechanism in 
which these genes compete for LCR function. An advantageous feature of the human system is 
that perturbations of LCR looping leave unaltered endogenous nuclear factors, the LCR per se, 
and the maturation state of the cells. 
We infected primary human cultures with lentiviral vectors expressing either GFP (control) 
or hZF-SA, purified infected cells by FACS, and quantified bursting parameters by RNA FISH. We 
observed that erythroblasts from different donors expressing control vector produced between 5 
and 35% g-globin and 65-95% b-globin. The variation between samples is presumably due to 
differences among donors or the way blood samples were obtained and processed. Forced 
enhancer-promoter looping between the LCR and g-globin promoter increased the burst fraction of 
g-globin transcription sites per cell, and decreased the burst fraction and size of b-globin sites 
slightly (Figures 2.4D-H, Figure A2.9), suggests the two genes compete for LCR activity. 
Furthermore, formation of g-globin-LCR contacts increased g-globin burst fraction without affecting 
g-globin burst size, consistent with the results from the murine cell line (Figures 2.4E-H). Changes 
in burst fraction corresponded to changes in mRNA levels in the same samples: g-globin mRNA 
increases with hZF-SA, while  b-globin trends downward (Figure A2.4B-C). The human LCR thus 
governs burst fraction of target genes via enhancer-promoter contact, while governing burst size 
through another independent mechanism.  
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Figure 2. 5: b- and g-globin promoters compete for enhancer activity when positioned in 
cis. A) Representative image of a primary human erythroid cell co-transcribing b- and g-globin from the same 
allele. B) Model of how allelic b- and g-globin transcription was quantitated using RNA FISH data. C) Example 
quantification of cellular b- and g-globin transcription for one donor. Fisher exact test odds ratio=0.66, p-
value=0.13. D) Fisher exact test odds ratio and 95% confidence interval for 4 human samples for cis-
competition of globin alleles, estimating 3.2 alleles per cell. E) Fluorescence intensity of β-globin transcription 
sites in primary human cells, either non-colocalized transcription sites or those colocalized with γ-globin 
transcription sites. p=0.4, Wilcoxon paired rank-sum t-test, N=4 donors. F) Fluorescence intensity of b- and g-
globin transcription sites for each co-transcriptional transcription site, Pearson R2=0.003, N=4 donors. See 
also Figures A2.5 and A2.10. 
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2.7 Allelic but not cellular co-transcription is disfavored in primary human erythroblasts  
 
We observed co-transcription of b- and g-globin on the same chromosome in a fraction of 
cells, as shown by colocalized g-globin and b-globin intron RNA FISH signals, suggesting that 
competition between different globin genes might be not absolute (Figure 2.5A). Similar co-
transcription of globin genes had been previously observed in murine systems114,115,201,202. Allelic 
co-transcription could mean (1) that the LCR switches rapidly between the b-globin and g-globin 
genes to alternately trigger bursts, (2) that the LCR acts on both genes simultaneously, or that (3) 
occasional transcription of one or both genes occurs in an enhancer-independent manner. If the 
LCR truly switched rapidly (Model 1), co-transcriptional events should be less frequent than 
expected than if the two genes were transcribing independently. 
To test whether co-transcription is indeed statistically disfavored, we first examined 
whether b- and g-globin are transcribed independently in the same cell, regardless of whether the 
two genes are transcribed from the same chromosome or not.  We quantified cells transcribing b-
globin, g-globin, both or neither, and then performed a Fisher exact test for independence of their 
transcription (Figure A2.5A-C). The null hypothesis is that a cell transcribing b-globin has the same 
likelihood of transcribing g-globin as a cell NOT transcribing b-globin. This is represented by an 
odds ratio of one. Alternatively, an odds ratio less than one would show negative correlation 
between transcription of the two genes in a single cell, potentially suggesting some trans regulation 
mediating competition between the genes. We found that the odds ratio was not consistently 
greater or less than 1 in our analysis of the cells of 4 donors (Figure A2.5C). This suggests that on 
a cellular level, transcription of b- and g-globin is independent. 
Next, we investigated whether co-transcription on a single allele copy of g- and b-globin 
was independent, treating all alleles as a pool irrespective of which cell they were in. This analysis 
required estimating the number of non-transcribing alleles in the population, which is not 
measurable by RNA FISH. We thus performed cell cycle analysis of cultured human cells using 
RNA FISH: cells with histone 4 mRNA are in S-phase, cells without histone 4 mRNA with a small 
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nucleus are in G1, while cells without histone RNA with a larger nucleus are in G2 (Padovan-Merhar 
et al., 2015). Using this method, we found that 40% of cells were in G1, 31% in S, and 29% in G2 
(Figure A2.5D). Since the b-globin locus is early-replicating in erythroid cells207  we conservatively 
assumed that each S and G2 cell had 4 copies, resulting in an average of 3.2 copies per cell (40% 
of 2 alleles + 60% of 4 alleles =3.2 alleles). However, we also carried out calculations with different 
possible numbers of alleles: 2.6 alleles (which assumes that globin is replicated at the end of S 
phase) and 3 alleles (if globin is replicated near the middle of S) (Figure A2.5E-F). 
Using this estimate for allele number, we quantified allelic transcription in cells from four 
human donors. Cotranscription in cis represented 1.1% to 3.0% of total globin locus copies 
depending on the donor (example shown in Figure 2.5C). We then measured the relationship 
between transcription of  b- and g-globin in cis using the Fisher exact test (Figure 2.5B-D, Figure 
A2.10). The results suggest that allelic co-transcription of b- and g-globin is mutually inhibitory, with 
odds ratios ranging from 0.39 to 0.76 depending on the donor (Figure 2.5B-D). Note that this was 
the most conservative measurement of the odds ratio of allelic b- and g-globin co-transcription. If 
the globin locus were not replicated at the very beginning of S phase in all cells, then the average 
number of alleles per cell would be less than 3.2. Estimating either 3.0 or 2.6 globin alleles per cell 
on average reduces the odds ratios for each donor, and decreases all p-values below p=0.05 
(Figure A2.5E-F). This analysis therefore supports the model that the LCR rapidly switches 
between promoters to allow co-transcriptional events to occur. In contrast, if the LCR could act on 
both genes at once or if one gene could transcribe without LCR contact (Models 2 and 3), we would 
expect to see cotranscription occurring at a higher rate.  
Strikingly, we found that the average burst sizes of genes that are co-transcribing are not 
significantly different from those genes that are not, consistent with the model of dynamic enhancer 
switching (model 1) and the finding above that changing enhancer-promoter contacts does not alter 
burst size (Figure 2.5E). 
If the LCR switches dynamically between genes (model 1) a further prediction would be 
that g-globin burst sizes would not be correlated with b-globin burst sizes because bursts detected 
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by FISH appear largest in the middle of the bursting interval and dimmer during the beginning and 
end of the burst. In contrast, model 2 (simultaneous contacts of the LCR with both globin genes) 
would predict a positive correlation in the burst sizes since LCR activity on a target gene increases 
burst size. We observed a lack of correlation between allelic g- and b-globin burst sizes, consistent 
with transcription of the two genes occurring in a staggered fashion and lending further support for 
model 1 (Figure 2.5F).  
In sum, all our results agree with a model in which the LCR interactions with the  -globin 
gene disfavor those with the b-globin gene and vice versa, accounting for competition between the 
two genes. Definitive evidence for this model would require direct imaging of LCR-promoter 
contacts in live cells, which is not yet possible.  
 
2.8 Discussion 
 
We employed single-molecule RNA FISH to quantify transcriptional bursting parameters at 
the murine and human b-globin loci during cellular differentiation and following targeted changes 
to LCR-promoter contacts. During erythroid maturation both b-globin burst fraction and burst size 
increase. Deletion of the LCR dramatically reduces burst fraction with comparatively modest effects 
on burst size. In order to selectively interrogate the influence of LCR-promoter contacts on bursting 
parameters, looped contacts were forged via targeted tethering of the self association domain of 
Ldb1. Forced enhancer-promoter contacts increased burst fraction without affecting burst size. In 
concert, these findings suggest a connection between enhancer-promoter contact frequencies and 
burst fractions. The g-globin and b-globin genes positioned in cis can be co-expressed but compete 
for LCR contacts and tend not to be initiated simultaneously, consistent with rapidly alternating and 
highly flexible looped enhancer promoter contacts.  
The finding that the LCR influences both the increase in burst fraction and size is consistent 
with a previous report113. However, single molecule RNA FISH experiments in the present study 
enabled a more quantitative assessment of burst parameters, revealing that augmenting burst 
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fraction is the predominant mechanism by which the LCR enhances b-globin transcription. To 
bypass potential secondary effects of LCR deletion and to examine the consequences specifically 
of LCR-promoter contact frequency on bursting parameters, we employed a forced LCR-promoter 
looping approach. Notably, the looping inducing construct ZF-SA triggered increases burst 
frequency to the same extent as did GATA1-induced maturation but without modulating burst size. 
We saw essentially the same behavior in primary human cells under conditions in which the LCR 
associated protein complexes and cell maturation stage are presumed to be largely unperturbed. 
This confirms that the major regulatory function of the LCR is to increase the likelihood of the b-
globin genes to be actively transcribed. These conclusions are in line with observations made with 
live cell imaging, which showed that increasing levels of transcription factor binding to a reporter 
construct predominantly increased burst fraction with little effect on burst size or duration208. 
These data beg the question of how exactly enhancer looping governs burst occurrence. 
Is enhancer-promoter contact required only to initiate a transcriptional burst or does it have to 
persist for the duration of the burst? Solving this issue definitively would require both live imaging 
of transcription as well as measuring the duration of enhancer-promoter contacts in live cells, the 
latter of which is technically difficult. The observation that cotranscriptional spots of g-globin and b-
globin only persist for a few minutes after cessation of transcription, suggests that enhancer-
promoter contacts and the resulting transcriptional burst are indeed very dynamic on a scale of 
minutes in the case of this locus. We acknowledge that temporal inferences on LCR promoter-
contact oscillations and burst lengths are limited by the half-life of the intron used to image 
transcription. Therefore, it remains possible that either the contacts durations and/or the burst 
lengths are even shorter than our measurements allow.  
It remains unclear how regulatory elements such as the LCR contribute to burst size during 
cell maturation, although our data suggests that the mechanism is independent of enhancer-
promoter contact. One possibility is that increases in transcription factor occupancy at the locus or 
progressive changes in histone modifications that accompany maturation promote RNA 
polymerase density or processivity209–211. LCR deletion may block such maturation-induced 
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changes: LCR deletion in G1E-ER4 cells led to reduced occupancy at the promoter by GATA1 
(unpublished observation). However, loss of the LCR in whole animals left chromatin accessibility, 
histone acetylation and transcription factor occupancy at the promoters largely intact52,80,198,199. The 
LCR may also contribute to burst size by stimulating transcription elongation via physical contacts 
with the gene body212–214. Our forced looping approach predominantly facilitates enhancer contacts 
with the promoter, while increasing gene body contacts less than GATA1 induced maturation 
does79. An increase in elongation rate could allow more polymerase molecules to traverse the gene 
body in quick succession, thus increasing burst size. Therefore, decreased GATA1 occupancy, 
reduced LCR-gene-body contacts, or related consequences of LCR deletion likely account for the 
reduction in transcriptional burst size. However, we also acknowledge inherent technical limitations 
to the ability to distinguish burst size and fractions under conditions in which transcription is 
extremely rare, such as in the LCR-deficient cells.  
Co-expression in cis of g-and b-globin genes could result from simultaneous contacts of 
the LCR with both genes; or from rapidly alternating contacts of the LCR to the two genes such that 
one interaction disfavors the other. Our results clearly support the latter model since active 
transcription of one gene lowers the probability of transcription of the other gene. Additional support 
for alternating LCR-gene contacts derives from the lack of correlation in burst sizes between g- and 
b-globin genes co-transcribed in cis. Prior experiments involving pharmacologic transcription 
elongation blockage followed by release into productive elongation showed that reappearance of 
co-transcriptional FISH signals for globin genes in cis re-appeared slower than signals from 
individually transcribing genes115.Together with experiments showing that the LCR promotes 
phosphorylation of RNA polymerase II and elongation72,80, the simplest model accommodating prior 
and current findings is that the LCR forms looped contacts with the promoters to increase the 
probability of paused RNA polymerase to convert into the actively elongating form.  
If two genes in cis compete for LCR function in a mutually exclusive manner no co-
transcription should be detected, yet co-transcription appears at approximately 1.1% to 3.0% of 
alleles. However, RNA FISH experiments are limited in their temporal resolution by the half life of 
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the introns under investigation. In our experiments, duration of RNA FISH signals was measured 
to average ~10 minutes following transcription inhibition. Thus, any fluctuations in LCR-gene 
contacts at a time scale below 10 min would appear as co-transcription even if LCR-promoter 
contacts are entirely mutually exclusive. However, we cannot not rule out rare simultaneous LCR 
contacts or occasional enhancer-independent firing that might lead to truly concurrent transcription. 
Addressing such possibilities might be feasible once live imaging techniques have reached the 
required spatial and temporal resolution. 
Future studies will examine the generality of enhancer effects on transcriptional bursting. 
The LCR is a well-studied example, but distinct modalities of enhancer actions are a likely 
possibility. Moreover, different drug treatments or transcription factor perturbations may alter 
bursting in other ways that may help understand the molecular underpinnings of transcriptional 
control. 
2.9 Experimental Procedures 
  
Murine cell culture, infection and sorting 
G1E cells and G1E-ER4 cells were cultured and differentiated as described (Weiss 1997). 
Cells were infected with the MIGR-1 retrovirus expressing only GFP or mZF-SA followed by an 
IRES element and GFP79. Infections were performed as described47. Cells were expanded for two 
days and sorted using a BD FacsAria to purify GFP+ infected cells from control and mZF-SA 
samples. Finally, estradiol was added for 9 hours and transcription was measured by FISH or 
qPCR. 
  
Human primary cell culture, infection and sorting 
Human peripheral blood mononuclear cells were obtained from de-identified healthy blood donors 
after informed consent by the University of Pennsylvania Stem Cell Core.  CD34+ hematopoietic 
precursor cells were isolated from peripheral blood mononuclear cells using CD34+ magnetic bead 
positive selection. Cells were expanded in SFEM media (StemCell) with 10-6M hydrocortisone 
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(Sigma Aldrich), 100 ng/ml SCF, 5ng/ml IL-3, 100ng/ml erythropoietin (Peprotech), protocol 
adapted from206,215,216 . For FISH studies measuring co-transcription, cells were examined after 9-
12 days of expansion. 
For hZF-SA experiments, cells were infected after 8-11 days of expansion. hZF-SA was expressed 
in a lentivirus driven by the ankyrin promoter, and coupled to IRES-GFP. The control vector 
expressed only GFP112. Infections were carried out as described112. The expansion phase was 
extended for 7 more days, and then cells were sorted and examined. 
For human erythroid maturation experiments, cells were expanded for 11 days after isolation, then 
cells were differentiated for 3 days in SFEM with 3U/ml erythropoietin without other cytokines such 
that d0 and d3 (as in Figure 2.4A-B) correspond to day 11 and d14 of total culture respectively. 
Actinomycin D treatment was performed by adding 1 microgram/ml of actinomycin D to human cells 
for the stated period of time, after 8-11 days of expansion of cells. 
 
Generation of enhancer-deleted G1E-ER4 cells 
Cas9 and guide RNA plasmids were transiently co-transfected into G1E-ER4 cells using an 
Amaxa Nucleofector 2b (Lonza, program G-016, reagent kit R). Transfected single cells were 
sorted into a 96 well plate using a FACS Aria II (BD Biosciences). Single cell clones were 
expanded and screened by PCR, followed by DNA sequencing.  
 
Chromatin Immunoprecipitation 
We performed ChIP as previously described217, using the N-20 Pol II antibody (Santa Cruz sc899). 
ChIP-qPCR was performed with Power SYBR Green (Invitrogen).  
  
RT-qPCR 
We isolated RNA using TRIzol (Life Technologies). Reverse transcription was performed with 
iScript (Bio-Rad). qPCR was performed with Power SYBR Green (Invitrogen).  
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Single-molecule RNA FISH imaging 
We performed single-molecule RNA FISH as described previously203. Briefly, we fixed cells in 
1.85% formaldehyde for 10min at room temperature, and stored them in 70% ethanol at 4 degrees 
C until imaging. FISH probes consisted of oligonucleotides conjugated to fluorescent dyes.  We 
hybridized pools of FISH probes to samples, followed by DAPI staining and wash steps performed 
in suspension. Samples were cytospun onto slides for imaging on a Nikon Ti-E inverted 
fluorescence microscope. 
  
Image Analysis 
We manually segmented boundaries of cells from bright field images and localized RNA spots using 
custom software written in MATLAB, with subsequent analyses performed in R. Transcription sites 
for mouse b-globin, Gata2, and human g-globin are identified by co-localization of spots in the intron 
and exon channels for a given mRNA, and for human b-globin by bright nuclear intron spots. Alleles 
co-transcribing human g-globin and b-globin are identified by colocalization of transcription sites. 
Fluorescence intensities of transcription sites were determined by 2D Gaussian fitting on processed 
image data.  
  
Plotting and graphics 
We used R packages dplyr and ggplot2 to produce nearly all figures, followed by cosmetic 
adjustments in Adobe Illustrator. Several figures were produced using Graphpad Prism. 
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CHAPTER 3: Transcriptional burst initiation and polymerase pause release are key 
control points of transcriptional regulation 
3.1 Introduction 
 
Since I showed that increasing enhancer-promoter contact increased burst fraction at the 
b-globin locus in human and mouse cells (Chapter 2), I next asked how generally important this 
mode of transcriptional regulation might be. To address this question, I examined multiple genes 
and perturbations to see whether bursting regulation or other types of transcriptional regulation 
were more prevalent. 
Studies using sequencing-based biochemical assays have suggested that transcriptional 
regulation primarily tunes two transcriptional steps: RNA polymerase II (Pol II) binding to a gene’s 
promoter and the release of Pol II from promoter-proximal pausing 1,5,25.  Both polymerase 
binding and polymerase pause release are required to produce RNA, and studies have 
extensively characterized the proteins involved in facilitating both these steps.  
However, given the data that bursting properties are regulated in some contexts (Chapter 
2), I asked whether the fluctuations between transcriptional activity and inactivity, which I will call 
burst initiation and termination, might be regulated along with the steps of polymerase binding 
and polymerase pause release. The transitions between the transcriptionally-active state and the 
transcriptionally-inactive state are typically slower than the time required for polymerase binding 
and polymerase pause release (hours vs. tens of minutes)37,38,150,166,180,218 . Therefore, changes to 
burst initiation and burst termination may form an independent layer of regulation superimposed 
on top of polymerase binding and polymerase pause release: each time a burst is initiated, 
multiple RNAs can be made by repeated cycles of polymerase binding and release. If burst 
initiation and termination are regulated, it is unclear how those steps relate to the steps of 
polymerase binding and pause release: either burst initiation could permit polymerases to bind to 
facilitate transcription of multiple RNAs quickly during a burst, or burst initiation could instead 
facilitate transcription by permitting bound polymerases to release from pausing. It is also unclear 
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whether regulation of bursting, polymerase binding and pause release are all equally important to 
mediate changes in gene expression. 
To identify which of these steps of transcription are tuned, we first need to determine how 
polymerase binding and pause release fit together with bursting; specifically, whether polymerase 
binding occurs in bursts or if polymerase pause release occurs in bursts. It has proven difficult to 
distinguish these possibilities in part because single cell and population-averaging biochemical 
measures of transcription give different types of information: only single cell methods such as 
nascent transcript RNA FISH can be used to measure bursting properties such as burst fraction 
and intensity, while biochemical methods like Pol II ChIP-seq have been used to measure 
polymerase binding and pause release. We hypothesized that combining these methods could 
clarify how bursts relate to polymerase binding and pause release, and could thereby allow us to 
identify which transcriptional steps are regulated by perturbations. Nascent transcript RNA FISH 
uses probes specific to introns of a gene of interest to measure transcription of that gene in single 
cells, thus measuring average changes in burst frequency and amplitude163,170,219. In contrast, Pol 
II ChIP-seq (and similar approaches like NET-seq and PRO-seq) measures average changes in 
polymerase occupancy and pause release61,150,154,155,220,221. Using both these types of methods to 
simultaneously measure changes in bursting properties as well as polymerase occupancy and 
pause release should allow us to clarify whether either polymerase binding occurs in bursts or 
polymerase pause release occurs in bursts. 
To determine which steps of transcription are changed by biological perturbations, we 
first constructed several possible models of transcription that fit together bursting with polymerase 
binding and pause release steps, including one framework where burst initiation permits 
polymerase to bind (‘polymerase binding occurs in bursts’) and another where burst initiation 
permits release of bound polymerases (‘polymerase pause release occurs in bursts’). Each 
framework made distinct predictions for how nascent transcript RNA FISH and Pol II ChIP-seq 
measurements should change in response to perturbations. We then performed both nascent 
transcript RNA FISH and Pol II ChIP-seq in the presence of a number of global and gene-specific 
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perturbations, and compared the results to the models’ predictions. This approach revealed that 
polymerase binding can only occur after a burst is initiated, and excluded the possibility that burst 
initiation permits pause release of pre-bound polymerase. We then used our experimental data 
with this ‘polymerase binding occurs in bursts’ model of transcription to show that the alteration of 
burst initiation and polymerase pause release rates accounted for the majority of changes in the 
overall rate of transcription. In contrast to what was previously expected58,138, most perturbations 
that we examined seemed not to greatly change the rate of polymerase binding in our system. 
Our study supports a model of transcription in which polymerase binding occurs in bursts, and it 
implicates transcriptional burst initiation and polymerase pause release as critical control points in 
transcriptional regulation. 
 
3.2 Identifying the regulated steps of transcription requires selection of a model of 
transcription 
 
In order to ultimately identify which steps of transcription are regulated by complex 
biological perturbations, we first needed to clarify how transcriptional bursting regulation fits 
together with polymerase binding and pause release regulation. We built quantitative models of 
transcription, each with a different configuration of the processes of burst initiation, polymerase 
binding, and pause release (Figure 3.1A). In each, we used simulations to determine what the 
experimental outcomes would be for changing the rates of specific processes, with the hypothesis 
that changing different rates would lead to a distinct set of experimental changes, ultimately 
allowing us to determine which rates were changing in complex biological perturbations. A key 
feature required of our models was that transcription occur in a bursting pattern (given that all 
genes we have examined show this behavior, Figure A3.1A). In one model, this bursting occurs 
because polymerase binding only occurs during transcriptionally active periods (‘polymerase 
binding occurs in bursts’). In the other model, polymerase binding could happen any time, 
irrespective of whether the gene is active or not, and instead it is pause release that only occurs 
during transcriptionally-active periods (‘polymerase pause release occurs in bursts’). 
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To determine the experimental predictions of these two models of transcriptional 
regulation, we used Gillespie stochastic simulations to model a thousand gene copies that over 
time proceeded through the steps in a model framework: burst initiation, polymerase binding, 
polymerase pause release, and burst termination222. We then used the molecular events 
occurring over time in each thousand-gene-copy simulation to predict the resulting Pol II ChIP-
seq and nascent transcript RNA FISH outcomes as follows. The mean polymerase binding along 
all gene copies was averaged to create a simulated Pol II ChIP-seq profile. We used this 
predicted Pol II ChIP-seq profile to calculate the Pol II traveling ratio: the ratio between gene body 
and promoter-proximal polymerase, which has been used to measure changes in pause release 
rate (although we note that experimentally, promoter-proximal Pol II includes both paused and 
early-transcribing polymerase61,155,220,221 ). Next, we used the number of polymerases that 
underwent pause release and produced nascent RNA over time for each gene copy to predict 
measurements from nascent transcript RNA FISH, a method that measures recent transcription in 
single cells using fluorescent probes specific to introns (Figure 3.1C, Figure A3.1B).  Nascent 
transcript RNA FISH probes bind to nascent RNA to create a fluorescent spot near a gene’s 
location in the nucleus (a ‘transcription site’) if a gene has transcribed recently (Figure 3.1C). We 
predicted the average number of active transcription sites per cell (the proportion of gene copies 
active at a time) and the mean transcription site fluorescence intensity (which measures the 
average number of RNAs recently transcribed by a single gene copy). We then repeated such 
simulations while changing the value of each rate parameter one at a time (Figure A3.3E). Thus 
our simulations generated predictions for how changing specific rates of transcriptional steps 
would change both Pol II ChIP-seq (population) and nascent transcript RNA FISH (single cell) 
measurements of transcription.  
In this way, we made predictions for the effects of changing specific rates on the fold 
change in experimental measurements for both models of transcriptional regulation (Figure 3.1B, 
Figure A3.2A, Figure A3.6; see Figure A3.3 for other models examined). For each model, we 
found that changes to the rates of burst initiation, polymerase binding or pause release each 
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resulted in a distinct signature of experimental outcomes. Moreover, these signatures revealed a 
critical distinction between the two models: we predicted that altering the burst initiation rate 
would change the Pol II traveling ratio in the ‘polymerase pause release occurs in bursts’ model, 
but not in the ‘polymerase binding occurs in bursts’ model. 
 
3.3 Combining nascent transcript RNA FISH and Pol II ChIP-seq reveals that 
polymerase binding occurs in bursts 
 
Based on our simulations, by changing each step of transcription experimentally we 
should be able to first verify the shared experimental signatures of the two models, and then we 
could change the rate of burst initiation to select between the two models using the behavior of 
the Pol II traveling ratio (Figure 3.1B). We first changed the rate of polymerase pause release, 
with both the ‘polymerase binding occurs in bursts’ and ‘polymerase pause release occurs in 
bursts’ models predicting that all transcriptional measures should decrease: transcription sites per 
cell and transcription site intensity measured by nascent transcript RNA FISH, and Pol II traveling 
ratio measured by Pol II ChIP-seq (Figure 3.1A-B). Intuitively, if pause release occurred less 
frequently, a gene would be associated with nascent RNA for a lower fraction of the time (less 
transcription sites per cell), each time a gene is actively transcribing there would be fewer RNA 
molecules at a time (lower transcription site intensity), and Pol II would be released into the gene 
body less frequently (lower Pol II traveling ratio). We used flavopiridol to reduce the rate of pause 
release; flavopiridol inhibits the p-TEFb kinase complex150,218,223. As predicted by both models, we 
found decreased transcription sites per cell, decreased transcription site intensity, and decreased 
Pol II traveling ratio. Pol II traveling ratio was calculated using genes that maintained detectable 
Pol II occupancy after drug treatment (gene properties shown in Figure A3.1C), and was robust to 
choice of 3’ Pol II binding region used as the numerator for the traveling ratio (Figure A3.1F). 
(Importantly, though some publications have applied high-dose flavopiridol to block new pause 
release and then have immediately measured transcription, in order to examine the properties of 
the receding wave of elongating Pol II, in our experiments we used lower drug doses and 
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measured transcription only after 60 minutes, so we could instead measure a new steady state of 
transcription with a reduced pause release rate218.) 
Note this experiment also eliminated the commonly used telegraph model model of 
transcription (Figure A3.3A). The telegraph model does not include an independently regulated 
pause release step. Thus, it has been sufficient to predict the distribution of mRNA levels in a cell 
population, but it cannot distinguish the effects of changing polymerase pause release versus 
polymerase binding rates163,178,181,208. The fact that changing the pause release rate changed the 
Pol II traveling ratio is inconsistent with the telegraph model (Figure A3.3A). 
We next tested the predictions of our two models for the effect of changing the 
polymerase binding rate. Both the ‘polymerase binding occurs in bursts’ and the ‘polymerase 
pause release occurs in bursts’ models predicted that reducing polymerase binding would reduce 
transcription sites per cell and transcription site intensity but, unlike reducing the pause release 
rate, would leave Pol II traveling ratio unchanged. (The reason that transcription sites per cell are 
decreased is because of the period of time the gene is active, the percentage of that time during 
which there is a nascent transcript from an active polymerase would be less as the polymerase 
binding rate decreased.) We treated G1E-ER4 cells with triptolide to reduce the polymerase 
binding rate by inhibiting the helicase activity of TFIIH (Figure 3.1E)150,218,224–226. As predicted, 
triptolide treatment decreased both the transcription sites per cell and the transcription site 
intensity, while leaving the Pol II traveling ratio unchanged (Figure 3.1E, Figure A3.1D). This 
experiment supported the predictions of the two models and confirmed that we could 
experimentally distinguish a change in polymerase binding rate from a change in polymerase 
pause release rate. Together, these two experiments supported the predictions of both our 
models. 
We then sought to change the burst initiation rate to determine whether transcriptional 
regulation was more consistent with the ‘polymerase binding occurs in bursts’ or the ‘polymerase 
pause release occurs in bursts’ model (Figure 3.1B). Both models predicted that changing burst 
initiation should change transcription sites per cell and should not change transcription site 
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intensity but they disagreed on the effect on Pol II traveling ratio. The ‘polymerase binding occurs 
in bursts’ model predicted no change in Pol II traveling ratio, while the ‘polymerase pause release 
occurs in bursts’ model predicted that increasing burst initiation should also increase the Pol II 
traveling ratio (Figure 3.1B). The molecular underpinnings of burst initiation are unclear, and there 
is no known pharmacological inhibitor of this transcriptional step. However, we previously showed 
that increasing enhancer-promoter contact for the Hbb-b1 gene using a synthetic looping factor 
increased transcription sites per cell without changing transcription site intensity227 . Both models 
predicted that such a result could only occur if forced enhancer-promoter looping changed the 
burst initiation rate. Therefore, we repeated this perturbation to see whether the Pol II traveling 
ratio changed or remained constant. We found that increasing promoter-enhancer contact did not 
alter the Pol II traveling ratio for Hbb-b1, suggesting that polymerase binding rather than pause 
release occurs in bursts for this gene. Thus our experimental data was most consistent with a 
framework in which a burst initiation step was required to permit polymerase binding to a gene 
(the ‘polymerase binding occurs in bursts’ model, Figure 3.1B). A caveat of the looping factor 
experiment was that we could only modulate burst initiation for one gene, but in Figure 3.2A we 
will show that erythroid differentiation changed burst initiation rate for the housekeeping gene 
Prdx2 in addition to Hbb-b1, arguing for the generalizability of the ‘polymerase binding occurs in 
bursts’ model. In sum, changing three steps of transcription experimentally demonstrated that the 
‘polymerase binding occurs in bursts’ model was most consistent with our data, providing a set of 
predictions we will subsequently use to identify transcriptional steps changed by complex 
perturbations.  
We also evaluated several other possible model structures, but none of these models 
were more consistent with our experimental data than the ‘polymerase binding occurs in bursts’ 
model (Figure A3.3B-D). A model in which there was no independent burst initiation step and only 
polymerase binding and pause release rates could be regulated (Figure A3.3B) was inconsistent 
with the experimental data in Figure 3.1F because it could never predict a change in transcription 
sites per cell independent of changes in transcription site intensity and Pol II traveling ratio. We 
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also considered a modified ‘polymerase binding occurs in bursts’ model, in which some 
proportion of polymerases drop off from the pause site rather than undergoing elongation (Figure 
A3.3D)150,228. This modification did not change the model’s predictions for the experimental 
effects of changing burst initiation, polymerase binding, or polymerase pause release rates. We 
also tested a model in which a refractory period of transcriptional silence occurred after each 
burst (Figure A3.3C). (Some live imaging studies have found evidence for refractory periods but 
some have not181,208 .) This model predicted that modulating the rate of escape from the 
refractory period escape would change transcription sites per cell but would not change 
transcription site intensity or Pol II traveling ratio, similar to the experimental result in Figure 3.1F. 
Our data is not inconsistent with this model, but our data also cannot show whether genes in our 
system transcribe with refractory periods. If indeed our genes transcribe with refractory periods, 
any change we herein ascribe to a change in burst initiation rate could also be achieved by a 
change in refractory period escape rate—either way, though, it is the effective rate at which the 
gene is reactivated that is subject to regulation. Thus, the possible regulation of refractory periods 
should be examined in future studies. This issue does not alter our ultimate conclusion that 
polymerase pause release and burst initiation/refractory period escape, and not polymerase 
binding, are the key regulated steps of transcription. 
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Figure 3. 1: Combining RNA FISH and Pol II ChIP-seq reveals that polymerase binding 
occurs in bursts A) Structure of the ‘polymerase binding occurs in bursts’ model and the ‘polymerase 
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pause release occurs in bursts’ model. B) Predictions of the models for how changing individual 
transcriptional rates should change nascent transcript RNA FISH and Pol II ChIP-seq measurements. See 
Figure A3.2A-B for the quantitative predictions that are summarized here. C) Schematics of nascent 
transcript RNA FISH and Pol II ChIP-seq. D) Top, representative images from nascent transcript RNA FISH 
and Pol II ChIP-seq after 60 minutes 100nM flavopiridol treatment of G1E-ER4 cells. Bottom, data 
summarizing nascent transcript RNA FISH and Pol II ChIP-seq after 0,10,100, or 1000 nM flavopiridol 
treatment for 60 minutes of G1E-ER4 cells that had been differentiated for 24 hours with 100nM estradiol to 
stabilize the GATA1-ER fusion protein expressed by the cells. n=3 biological replicates of nascent transcript 
RNA FISH (49-172 cells per gene per treatment per replicate, see Figure A3.1E, error bars display SEM) 
and n=3 biological replicates of Pol II ChIP-seq. For all figures, transcription sites per cell was measured by 
counting mean transcription sites, transcription site intensity was calculated as the mean fluorescence 
intensity of those sites calculated by 2D Gaussian fitting, and Pol II traveling ratio was calculated as (the Pol 
II density from the gene end to 1500bp past the gene end) divided by (the Pol II density 750 bp upstream to 
750 bp downstream of the transcription start site), although effects were robust to choice of 3’ region, see 
Figure A3.1F. For this figure, ChIP-seq data for ‘selected genes’ represents data for 5 genes corresponding 
to FISH experiments (Hbb-b1, Prdx2, Slc25a37, Slc4a1, and Tal1) and all genes represents 1416 genes still 
transcribed after drug treatment, see Figure A3.1C for characterization of genes. E) Nascent transcript RNA 
FISH and Pol II ChIP-seq after 0 or 300 nM triptolide was applied for 60 minutes to G1E-ER4 cells  that had 
been differentiated for 24 hours with 100nM estradiol. n=3 biological replicates of nascent transcript RNA 
FISH (81-202 cells per gene per treatment per replicate, error bars display SEM) and n=3 biological 
replicates of Pol II ChIP-seq. For this figure, ChIP-seq data for ‘selected genes’ represents data for 5 genes 
corresponding to FISH experiments (Hbb-b1, Prdx2, Slc25a37, Slc4a1, and Tal1) and all genes represents 
1416 genes still transcribed after drug treatment, see Figure A3.1C for characterization of genes. F) Nascent 
transcript RNA FISH and Pol II ChIP-qPCR after overexpression of looping factor or GFP-expressing empty 
vector control in G1E-ER4 cells that had been differentiated for 9 hours. n=3 biological replicates of nascent 
transcript RNA FISH (124-249 cells per treatment per replicate) and n=3 replicates of Pol II ChIP-qPCR. For 
this figure subsection, traveling ratio was calculated as (input-normalized ChIP-qPCR signal from the 3’ 
gene region) divided by (input-normalized ChIP-qPCR signal from the transcription start site region). 
 
 
3.4 Erythroid differentiation changes both burst initiation and polymerase pause release 
rates  
 
Having established that the ‘polymerase binding occurs in bursts’ model could 
successfully predict experimental outcomes of changing transcriptional steps, we next sought to 
apply this model to identify which steps of transcription are regulated by more complex biological 
perturbations. To investigate the transcriptional effects of erythroid differentiation, we 
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differentiated G1E-ER4 erythroid cells49  and performed both nascent transcript RNA FISH and 
Pol II ChIP-seq at several timepoints during differentiation. We expected that a complex biological 
process like erythroid differentiation would be associated with changes to multiple steps of 
transcription, but first we looked for the simplest type of scenario: genes where we could 
conclusively identify changes in individual steps of transcription. 
Early in differentiation, after 4 hours, both the Hbb-b1 gene, encoding an erythroid-
specific subunit of hemoglobin, and the Prdx2 gene, encoding a broadly-expressed antioxidant 
enzyme, had increased transcription sites per cell while their transcription site intensities and Pol 
II traveling ratios were unchanged (Figure 3.2A). According to the ‘polymerase binding occurs in 
bursts’ model, only a change in burst initiation could change transcription sites per cell without 
altering transcription site intensity or Pol II traveling ratio. Thus, we concluded that early erythroid 
differentiation specifically changes burst initiation for these genes. (Moreover, these data 
provided further support for the ‘polymerase binding occurs in bursts’ model and against the 
‘polymerase pause release occurs in bursts’ model: in the latter framework, transcription sites per 
cell cannot be changed without also changing either Pol II traveling ratio or transcription site 
intensity, Figure 3.1B.)  
Later in differentiation, after 13 hours, Hbb-b1 and Prdx2 had increased transcription 
sites per cell, transcription site intensity, and Pol II traveling ratio, which made it impossible to 
isolate just one specific rate as having changed at this timepoint for these genes (Figure 3.2B). 
Our model suggested that only a change in polymerase pause release rate could change Pol II 
traveling ratio, so erythroid differentiation must change at least polymerase pause release rate for 
these genes. (Other genes such as Gata2 and Myc also displayed changes in Pol II traveling ratio 
and thus pause release rate as we will discuss below, Figure 3.3B). However, we could not 
exclude additional changes in other rates beside pause release rate: for example, if pause 
release rate and polymerase binding rate both increased after 13 hours of differentiation, the 
‘polymerase binding occurs in bursts’ model would still predict increases in all three experimental 
measures: transcription sites per cell, transcription site intensity, and Pol II traveling ratio. So far 
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we concluded that erythroid differentiation changed both burst initiation (at 4 hours) and 
polymerase pause release rates (at 13 hours), and possibly other rates.  
 
Figure 3. 2: Erythroid differentiation changes both burst initiation and polymerase pause 
release rates. A) Nascent transcript RNA FISH and Pol II ChIP-seq after 4 hours of differentiation with 
100nM estradiol of G1E-ER4 cells for Hbb-b1 and Prdx2 genes. n=3 biological replicates of nascent 
transcript RNA FISH (274-534 cells per gene per treatment per replicate), n=2 biological replicates of Pol II 
ChIP-seq. B) Nascent transcript RNA FISH and Pol II ChIP-seq after 13 hours of erythroid differentiation 
with 100nM estradiol of G1E-ER4 cells for Hbb-b1 and Prdx2 genes, n=3 biological replicates of nascent 
transcript RNA FISH (84-665 cells per gene per treatment per replicate) and n=3 replicates of Pol II ChIP-
seq. 
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3.5 Combining modeling and experimentation suggests that erythroid differentiation does 
not greatly change polymerase binding rate 
 
Above, we identified which steps of transcription were changed in erythroid differentiation 
by measuring experimental changes one gene at a time, and comparing those data to qualitative 
model predictions for individual rate changes. However, we found that this logic fell short if 
multiple transcriptional rates changed simultaneously. The ‘polymerase binding occurs in bursts’ 
model, however, also makes predictions for how changing transcriptional rates affects the 
quantitative relationship between changes in nascent transcript RNA FISH and Pol II ChIP-seq. 
By measuring experimental changes across many genes, we sought to observe quantitative 
relationships between experimental changes to statistically identify which rates were most likely 
to be changing in the genes as a group. 
Specifically, the quantitative relationship between transcription site intensity and Pol II 
traveling ratio changes allowed us to distinguish changes in multiple rates. To step through this 
logic, changes in different individual rates were predicted to result in distinct relationships 
between transcription site intensity and Pol II traveling ratio changes (Figure 3.3A, left). Each 
point in Figure 3.3A represents the increase or decrease in experimental measurements 
predicted to result from either an increase or decrease in the indicated rate, with all the points 
displayed demonstrating a 1000 fold range of rate values. If polymerase pause release rate 
changed, both Pol II traveling ratio and transcription site intensity were predicted to change in a 
correlated manner (Figure 3.3A, top left): if a perturbation like differentiation increased pause 
release rate, both Pol II traveling ratio and transcription site intensity should increase.  A change 
in polymerase binding rate would instead change transcription site intensity but not change Pol II 
traveling ratio, resulting in a vertical line relationship (Figure 3.3A, middle left). (A similar outcome 
would result if burst termination rate was changed, Figure A3.4A). Finally, if burst initiation rate 
were changed, neither transcription site intensity nor Pol II traveling ratio were predicted to 
change greatly (Figure 3.3A, bottom left).  
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Figure 3. 3 Combining modeling and experimentation suggests that erythroid 
differentiation does not greatly change polymerase binding rate 
a. Predictions of the ‘polymerase binding occurs in bursts model’ for how changing one or multiple 
rates of transcription affects changes in transcription site intensity and Pol II traveling ratio. Each figure 
represents changing the indicated rates from intermediates value up or down, with a total 1000-fold range of 
possible values represented for each rate (See Figure A3.3E for parameter values tested).  
b. Fold change in transcription site intensity and Pol II traveling ratio for 7 genes after 13 hours of 
differentiation with 100nM estradiol of G1E-ER4 cells, n=3 biological replicates each of nascent transcript 
RNA FISH (84-665 cells per gene per treatment per replicate) and n=3 biological replicates of Pol II ChIP-
seq. Error bars display SEM. 
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Similarly, changes in different combinations of rates were predicted to result in distinct 
quantitative relationships between transcription site intensity and Pol II traveling ratio changes. 
Examination of individual genes above (Figure 3.2) showed that erythroid differentiation could 
change both burst initiation and pause release rates; if these were the only rates altered, the 
model predicted that Pol II traveling ratio and transcription site intensity would change in a highly 
correlated manner (Figure 3.3A top right, R2=0.95), with a relationship of approximately log(fold 
change transcription site intensity)= 0.55*log(fold change traveling ratio), although the slope of 
relationship depends somewhat on model parameters (Figure A3.4C).  This pattern of 
transcriptional changes is produced because changing the polymerase pause release rate 
produces a log y=0.55*log x relationship, while burst initiation rate has little effect on either x or y 
axis values (Figure 3.3A left). However, if polymerase binding rate were changed in addition to 
burst initiation and pause release rates, the model predicted that if we measured the effect of 
differentiation on number of genes, the changes in traveling ratio and transcription site intensity 
should NOT be strongly correlated (R2=0.39) (Figure 3.3A, bottom right). (Similarly if termination 
rate changed along with burst initiation and pause release rate, the changes in traveling ratio and 
transcription site intensity would also not be strongly correlated, Figure A3.4B.) Note that if two or 
more rates change, a range of behaviors can occur: a gene could display large changes in both 
rates, or a large change in the first and small change in the second, or vice versa, so multiple 
genes must be examined to characterize the whole range of experimental behaviors. 
With this prediction in hand, we examined how 13 hours of erythroid differentiation 
affected the quantitative relationship between Pol II traveling ratio and transcription site intensity 
changes (Figure 3.3B). We found that the changes in transcription site intensity and Pol II 
traveling ratio were strongly correlated (R2=0.88): for example, both Prdx2 and Hbb-b1 genes 
had increased transcription site intensity and Pol II traveling ratio, while both Myc (encoding a 
broadly-expressed transcription factor controlling proliferation) and Gata2 (encoding a 
hematopoietic stem cell transcription factor) genes had decreased transcription site intensity and 
Pol II traveling ratio. Moreover, this quantitative relationship fell near the log y= 0.55* log x 
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relationship predicted if only burst initiation and pause release were changed, with a slope of 
0.62. Taken together, experimental data for these genes suggest that polymerase binding rate 
was not greatly changed in erythroid differentiation. (We can similarly exclude a large change in 
burst termination rate, by comparing to Figure A3.4B). Thus we conclude that burst initiation and 
polymerase pause release are the main rates changed by erythroid differentiation. 
While our analysis suggested changes to mainly burst initiation and pause release in 
differentiation, the degree to which these rates changed is different for different genes. One 
hypothesis was that promoter accessibility could correlate to differential transcriptional changes, 
so we analyzed publicly available data to see whether the change in promoter DNAse sensitivity 
could predict the change in transcriptional measurements in response to differentiation (Figure 
A3.4D). We found no strong correlations. Further studies will be required to examine why different 
genes experience different transcriptional changes in response to erythroid differentiation. 
 
3.6 BET inhibition changes both burst initiation and polymerase pause release rates 
 
Given that previous literature had identified polymerase binding rate as a key target for 
transcriptional regulation, it was surprising that erythroid differentiation seemed not to greatly 
affect this rate. We thus examined several more complex biological perturbations to see whether 
they too chiefly affected burst initiation and polymerase pause release rates. 
We next asked which rates of transcription were changed by BET inhibitor treatment. 
BET inhibitor treatment blocks the transcriptional activator proteins BRD2, BRD3 and BRD4 from 
binding to chromatin, and may inhibit multiple facets of gene regulation including polymerase 
pause release and enhancer activity55,229,230. We first looked for genes where we could identify 
individual transcriptional rate changes produced by BET inhibitor treatment. Acute BET inhibitor 
treatment reduced mean transcription sites per cell for the Hbb-b1 gene without changing 
transcription site intensity or Pol II traveling ratio, showing that burst initiation was specifically 
reduced for this gene (Figure 3.4A). In contrast, for the genes Tal1, Slc25a37, and Slc4a1 (which 
encode an erythroid transcription factor and two solute channels highly expressed in erythroid 
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cells), all three RNA FISH and Pol II ChIP-seq measures were reduced (Figure 3.4B). Thus for 
these genes, at least polymerase pause release rate was changed but potentially also other 
rates. So by using an approach of identifying single rate changes gene by gene, we found that 
BET inhibition can change both burst initiation rate and polymerase pause release rate, and might 
potentially change other rates.  
 
3.7 Combining modeling and experimentation suggests that BET inhibition does not 
greatly change polymerase binding rate 
 
We next sought to distinguish whether BET inhibition might alter polymerase binding rate, 
or if mainly burst initiation and pause release rates were changed. We again measured nascent 
transcript RNA FISH and Pol II ChIP-seq changes in multiple genes in response to BET inhibitor 
treatment (12 genes in this case), and examined the quantitative relationship between changes in 
transcription site intensity and Pol II traveling ratio. 
If only burst initiation rate and polymerase pause release rate were altered by BET 
inhibition, the ‘polymerase binding occurs in bursts’ model predicted that Pol II traveling ratio and 
transcription site intensity would change in a highly correlated manner (R2=0.95), with a 
relationship of approximately log(transcription site intensity)= 0.55*log(traveling ratio) (Figure 
3.3A, upper right); while if polymerase binding rate were also changed, changes in traveling ratio 
and transcription site intensity should not be strongly correlated (R2=0.39, Figure 3.3A lower 
right). Examining 12 genes, including both the important erythroid genes shown in Figure 3.4 as 
well as housekeeping genes such as Pabpc1 and Hnrnpl, we found that BET inhibition produced 
a strongly correlated relationship between changes in Pol II traveling ratio and transcription site 
intensity (R2=0.77) falling near the log(transcription site intensity)= 0.55*log(traveling ratio) line 
(Figure 3.5A), with a slope of 0.41. We thus concluded that BET inhibitor treatment did not greatly 
change polymerase binding rate. 
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Figure 3. 4: BET inhibitor treatment changes both burst initiation and polymerase pause 
release rates. A) Representative and summary nascent transcript RNA FISH and Pol II ChIP-seq after 60 
minutes of JQ1 BET inhibitor treatment of G1E-ER4 cells differentiated for 24 hours with 100nM estradiol for 
the Hbb-b1 gene, n=3 biological replicates of nascent transcript RNA FISH (72-306 cells per replicate per 
experiment) and n=3 replicates of Pol II ChIP-seq. B) Nascent transcript RNA FISH and Pol II ChIP-seq after 
60 minutes of JQ1 BET inhibitor treatment of G1E-ER4 cells differentiated for 24 hours with 100nM estradiol 
for Slc25a37, Tal1, and Slc4a1 genes, n=3 biological replicates of nascent transcript RNA FISH (94-195 
cells per replicate per experiment)  and n=3 biological replicates of Pol II ChIP-seq. Top, representative RNA 
FISH and Pol II ChIP-seq data. 
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This analysis raised the question of why different genes experienced changes in rates of 
different transcriptional steps in response to BET inhibitor treatment. We analyzed publicly 
available data to see whether Histone 3 lysine 27 acetyl levels at gene promoters could affect the 
change in transcriptional measurements in response to BET inhibition, since BET proteins bind to 
acetylated histones. We found that promoter H3K27ac weakly correlated to change in 
transcription sites per cell in response to BET inhibition (Figure A3.5B), but not to changes in 
other transcriptional measurements. Further studies will be required to examine why different 
genes experience different transcriptional changes in response to this perturbation. 
Some previous studies had suggested that BET inhibition might alter transcriptional 
elongation rate, a rate that was held constant in the ‘polymerase binding occurs in bursts’ model. 
To exclude this possibility, we blocked transcriptional pause release using DRB, and then allowed 
transcriptional elongation to resume in the presence or absence of BET inhibitor. By measuring 
the time it took to transcribe from an early to a late region of the nascent RNA using RNA FISH, 
we calculated the effect of BET inhibitor on elongation rate (Figure A3.5A). We found for the 
Zfpm1 gene that BET inhibitor did not affect the elongation rate greatly, and that our calculated 
estimate for the elongation rate, 2.0 kilobases per minute, was similar to that from previous 
studies, (2-5 kilobases per minute98,218,231 ). 
 
3.8 Combining modeling and experimentation suggests that Slc25a37 enhancer 
mutation does not greatly change polymerase binding rate 
 
We also used the ‘polymerase binding occurs in bursts’ model to examine what rates 
were changed by enhancer mutagenesis of the lineage-specific Slc25a37 (mitoferrin-1) enhancer. 
The Xu group70  previously created a series of G1E-ER4 cell lines with partial and full deletions of 
the large Slc25a37 enhancer region which reduced the RNA output of the target gene (encoding 
an erythroid-specific mitochondrial iron transporter) to varying degrees (Figure A3.5C-D). We 
performed nascent transcript RNA FISH and Pol II ChIP for Slc25a37 in the three partial-
enhancer-deletion and one full-deletion cell lines to examine which rates are changed. The 
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enhancer-deletion cells had correlated reductions of Pol II traveling ratio and transcription site 
intensity (R2=0.89) falling near the log(transcription site intensity)= 0.55*log(traveling ratio) line, 
with a slope of 0.70 (Figure A3.5E). (Our modeling suggests that these enhancer mutations likely 
also reduce burst initiation rate, due to the strong reduction produced in Pol II promoter 
occupancy.) Thus, mutation of the Slc25a37 enhancer reduced polymerase pause release rate, 
but appeared not to greatly change polymerase binding rate.  
 
Figure 3. 5: Combining modeling and experimentation suggests that BET inhibitor 
treatment does not greatly change polymerase binding rate. A) Fold change in transcription 
site intensity and Pol II traveling ratio for 12 genes after 60 minutes of 250nM JQ1 BET inhibitor treatment of 
G1E-ER4 cells differentiated for 24 hours with 100nM estradiol, n=3 biological replicates of nascent 
transcript RNA FISH (72-306 cells per gene per replicate per experiment) and n=3 biological replicates of 
Pol II ChIP-seq. Error bars display SEM. 
 
 
In sum, we developed a modeling and experimental approach to identify changes in 
transcriptional steps caused by complex perturbations. Surprisingly, we found that no 
perturbations aside from the targeted inhibitor triptolide seemed to strongly alter polymerase 
binding rate, while the main regulated steps of transcription were burst initiation and polymerase 
pause release. 
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3.9 Discussion 
 
We sought to determine which steps of transcription are biologically regulated. To this 
end, we combined both single cell and bulk biochemical measures of transcription in order to 
measure changes to rates of bursting as well as rates of polymerase binding and pause release 
upon various regulatory stimuli. This approach revealed that polymerase binding, rather than 
polymerase pause release, is confined to active transcriptional periods, clarifying how bursting fits 
together with biochemical steps of transcription. We then applied a number of biological 
perturbations and found that burst initiation and polymerase pause release were the main 
regulated steps of transcription. Polymerase binding rate was not altered by the perturbations we 
examined except by triptolide, which is a known inhibitor of polymerase binding. We note 
however that such experiments should be also performed with other genes and in other systems 
to confirm the generality of these conclusions. 
Importantly, this study showed that both Pol II ChIP-seq and nascent transcript RNA 
FISH were required to uniquely map changes in transcriptional steps to experimental changes. 
Nascent transcript RNA FISH distinguished between a change in polymerase binding rate and a 
change in burst initiation rate (using transcription site intensity), while Pol II ChIP-seq could not 
(Figure 3.1E-F). On the other hand, Pol II ChIP-seq but not RNA FISH could distinguish between 
changes in polymerase binding and polymerase pause release rates (Figures 3.1D-E). Therefore 
combining bulk and single-cell transcriptional measures is critical to determine which step of 
transcription was changed in a perturbation with unknown effects. 
Our results point primarily to burst initiation rate and polymerase pause release rate as 
key regulated steps in response to the various biological perturbations of our experiments. 
Polymerase binding rate appeared not to be subject to regulation by the biological perturbations 
we examined, but this does not mean that polymerase binding is not rate limiting. Indeed, 
polymerase binding rate was in fact rate limiting in the context of triptolide treatment. The finding 
that polymerase binding rate is not typically altered by biological perturbations corresponds well 
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to recent single molecule imaging studies of Pol II: the authors found that even when a gene was 
lowly transcribed, many molecules of polymerase clustered near its promoter37,38 . Since only one 
polymerase can bind a promoter at a time156, it is possible that polymerase binding typically 
occurs with a very high rate in all conditions. It would be interesting in future to examine whether 
each gene has its own consistent polymerase binding rate, and whether this could be encoded by 
gene promoters. 
Given that our study and others85,177,232  have revealed the key role that control of 
transcriptional bursting plays in gene regulation, it will be essential in future to better characterize 
the biochemical underpinnings of transcriptional bursting. An intriguing hypothesis with some 
experimental support is that burst initiation is related to enhancer-promoter looping85,227,232. Here, 
we have shown that for Hbb-b1, increasing enhancer-promoter contact specifically increases 
burst initiation, consistent with other studies that have isolated looping from other potential 
enhancer activities. It is possible that each time an enhancer contacts a promoter, the gene 
undergoes burst initiation. This hypothesis is supported by a recent paper showing that enhancer-
promoter looping occurs before every transcriptional burst85. Burst initiation could also be 
controlled by events independent from enhancer-promoter contact, such as transcription factor 
binding to the promoter or nucleosome remodeling. We believe that the ability to perform more 
biochemical assays in single cells will be required to understand the mechanistic basis of 
transcriptional bursts. 
Our experiments with BET inhibitor treatment show that BET proteins can regulate both 
burst initiation rate and polymerase pause release rate. Many papers in the literature have 
suggested that a chief transcriptional effect of BET inhibition was to inhibit polymerase pause 
release, and we also found that this is a dominant effect221,233–235 . However, we also observed 
significant effects of BET inhibitors on burst initiation rate: for example, BET inhibition of Hbb-b1 
only altered burst initiation rate and did not change polymerase pause release rate. Thus roles of 
BET proteins beyond just influencing polymerase pause release are likely to also be important for 
modulating gene expression55,229,230. Relatedly, an important future direction will be to explore 
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why different genes experienced changes in different rates of transcription in response to the 
same perturbation. 
Some studies have raised the possibilities of other forms of transcriptional regulation not 
included in the ‘polymerase binding occurs in bursts’ model, such as refractory periods between 
bursts181,236 or faster polymerase reinitiation after prior transcription237 . We tested a model 
including refractory periods (Figure A3.3C), which corresponded to our data equally as well as the 
‘polymerase binding occurs in bursts’ model. If there are refractory periods in our system, this 
modeling could suggest that the role we here attributed to burst initiation could be shared by the 
rate of escape from refractory period (i.e., early erythroid differentiation could regulate the rate of 
escape from a refractory period for Hbb-b1 and Prdx2, see Figure 3.2A). The data shown here 
does not require a refractory period as part of the transcriptional framework to explain the data, 
and we could not observe a refractory period using these methods, but our data also cannot 
exclude a role for refractory period regulation. However, some live imaging studies seem to 
exclude the presence of a refractory period173,183,208. Therefore, it is possible that more rates may 
be regulated in which we were not able to detect changes (e.g. refractory period escape or 
independent polymerase re-binding rate). 
Our study more generally demonstrates the utility of a model-based approach to 
identifying regulated transcriptional steps. In particular, previous studies of the burst initiation and 
termination phases have been largely phenomenological, characterized primarily by observables 
like burst frequency and transcription site intensity177,180,238,239. It has, however, proven difficult to 
discern any general rules or principles from these studies. Our study suggests that this may be 
due to the fact that these experimental observables can be convolved in counterintuitive ways; 
indeed, there is no reason a priori to believe that such observables map one-to-one to particular 
biological processes. For example, our study suggests that transcription site intensity was not 
independently regulated; rather, transcription sites per cell and transcription site intensity were 
both altered when polymerase binding or polymerase pause release are changed (Figure 3.1). By 
using a model-based approach informed by a combination of data types, we were instead able to 
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interpret these observables in terms of parameters of a simple model of transcription, thus 
revealing a more consistent underlying picture over a variety of perturbations.  
 
3.10 Experimental Procedures 
  
Murine cell culture, infection and sorting    
G1E cells were previously derived through deletion of GATA1 in mouse embryonic stem 
cells, followed by in vitro differentiation49. We cultured a subline of G1E cells, G1E-ER4, in which 
GATA-1-ER was transduced by retrovirus(Weiss et al., 1997). G1E-ER4 cells were induced to 
mature by the addition of 100nM estradiol to culture media. 
For differentiation experiments (Figures 3.2 and 3.3), cells were treated with estradiol for 4 or 13 
hours as noted in the figure. For flavopiridol experiments (Figure 3.1D), the noted concentration of 
flavopiridol (either 10nM, 100nM, or 1uM) was added for 60 minutes to cells differentiated for 24 
hours. For triptolide experiments (Figure 3.1E, Figure A3.1D), the noted concentration of 
flavopiridol (either 10nM, 100nM, 300nM, or 1uM) was added for 60 minutes to cells differentiated 
for 24 hours. For BET inhibition experiments (Figures 3.4 and 3.5), 250nM JQ1 was added for 60 
minutes to cells differentiated for 24 hours. For forced looping experiments (Figure 3.1F), cells were 
infected with the MIGR-1 retrovirus expressing only GFP or expressing mZF-SA followed by an 
IRES element and GFP79. Cells were infected, expanded for two days and sorted using a BD 
FacsAria to purify GFP+ infected cells from control and mZF-SA samples, estradiol was added for 
9 hours and transcription was measured by RNA FISH or ChIP-qPCR. For DRB transcriptional 
blocking to measure nascent transcript RNA FISH half-life (Figure A3.1B), 75uM DRB was added 
for 0, 10 or 60 minutes to cells differentiated for 24 hours. 
For experiments examining the Slc25a37 enhancer region (Figure A3.5), control and 4 
enhancer deletion G1E-ER4 cell lines created previously were kindly provided by the Jian Xu lab 
70. Cells were differentiated for 24 hours using estradiol and transcription was measured by RNA 
FISH or ChIP-qPCR. 
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For experiments to measure the Pol II elongation rate (Figure A3.5A), 75uM DRB was added to 
cells differentiated 21 hours. After 3 hours (24 hours differentiation), DRB was removed by washing 
and cells were fixed at 10-minute intervals after DRB removal. 
  
Chromatin Immunoprecipitation 
We performed ChIP as previously described217 , using the N-20 Pol II antibody (Santa 
Cruz sc899). For ChIP-sequencing, library construction was performed using Illumina’s TruSeq 
ChIP sample preparation kit (Illumina, catalog no. IP-202-1012) according to manufacturer’s 
specifications with the addition of a size selection using SPRIselect beads (Beckman Coulter, 
catalog no. B23318) prior to PCR amplification. Library size was determined (average ~340 bp) 
using the Agilent Bioanalyzer 2100, followed by quantitation using real-time PCR using the KAPA 
Library Quant Kit for Illumina (KAPA Biosystems catalog no. KK4835). Libraries were then pooled 
and sequenced on the Illumina NextSeq 500 using Illumina sequencing reagents according to 
manufacturer’s instructions.   
For perturbations in which only one gene was expected to change, forced enhancer-
promoter looping and Slc25a37 enhancer deletion, ChIP-qPCR was used to measure traveling 
ratio changes rather than ChIP-sequencing (Figure 3.1F, Figure A3.5C-E). Primers were tiled 
along Hbb-b1 and Slc25a37 respectively, and the ratio of TES-proximal to TSS-proximal 
promoter signal were used as traveling ratio, after normalizing to ChIP input. 
 
ChIP-sequencing analysis 
All Pol II ChIP-seq data was generated for this study, except the 0 and 13h G1E-ER4 differentiation 
(Figures 3.2 and 3.3), which was from240. We used bcl2fastq2 to convert and demultiplex the reads. 
We also applied fastQC to get read stats, Bowtie (0.12.8) to map reads to the mm9 genome 
(multiple and unique mappings), Samtools to convert SAM to BAM and get stats, MACS (1.3.7.1) 
to make wiggle files, and used wigToBigWig to convert wiggle files to bigWig files. 
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 We then performed bigWigAverageOverBed to find Pol II binding signal at transcription 
start site (TSS) region (750 bp upstream of transcription start site to 750 bp downstream), and 
transcription end site (TES) region (transcription end site to 1500 bp downstream of transcription 
end site), and calculated the Pol II traveling ratio for TES/TSS Pol II signal. (In Figure A3.1F, we 
instead calculated the Pol II traveling ratio by (gene body)/TSS, where gene body included 750 bp 
downstream of TSS to 1500 bp downstream of TSS.) We displayed data from only the genes with 
detectable Pol II binding in all regions in all experimental conditions, so that we could avoid 
examining genes that aren’t transcribed in one condition, by setting arbitrary cutoff values on the 
bigWigAverageOverBed results, and results were robust to changes in cutoff. To display Pol II 
ChIP-seq tracks in figures (e.g. Figure 3.1D), we displayed tracks normalized by number of aligned 
reads per sample.  
 For analysis of promoter DNAse hypersensitivity (Figure A3.4D), data was taken from 
(Hsiung et al. 2015). DNAse promoter sensitivity was determined using bigWigAverageOverBed in 
the TSS region (750 bp upstream to 750 bp downstream of TSS).  
 For analysis of promoter H3K27ac density (Figure A3.5B), data was taken from240 .DNAse 
promoter sensitivity was determined using bigWigAverageOverBed in the TSS region (750 bp 
upstream to 750 bp downstream of TSS). This same dataset was used for the H3K27ac track 
displayed in Figure A3.5C. 
 
Single-molecule RNA FISH imaging 
We performed single-molecule RNA FISH as described previously170,203 .. All probes used were 
complementary to introns of gene of interest (except the exon-targeted probe measures of mRNA 
shown in Figures A3.1A and A3.5C). All intron probes were approximately evenly spaced along 
length of RNA (except the transcriptional elongation rate measurements in Figure A3.5A, in which 
probes were placed at 5’ or 3’ end of Zfpm1). 
Briefly, we fixed cells in 1.85% formaldehyde for 10min at room temperature, and stored them in 
70% ethanol at 4 degrees C until imaging. We hybridized pools of FISH probes to samples, followed 
72 
 
by DAPI staining and wash steps performed in suspension. Samples were cytospun onto slides for 
imaging on a Nikon Ti-E inverted fluorescence microscope using a 100x Plan-Apo objective 
(numerical aperture of 1.43), a cooled CCD camera (Pixis 1024B from Princeton Instruments), and 
filter sets SP102v1 (Chroma), SP104v2 (Chroma), and 31000v2 (Chroma) for Cy3, Cy5, and DAPI, 
respectively. Custom filter (Omega) was used for Alexa594. We took 45 optical z-sections at 
intervals of 0.35 microns, spanning the vertical extent of cells, with 1s exposure time for Cy3, Cy5, 
and Alexa594, and 35ms for DAPI. 
  
Image Analysis 
We manually segmented boundaries of cells from bright field images and localized RNA spots using 
custom software written in MATLAB with subsequent analyses performed in R. Transcription sites 
were identified by bright nuclear intron spots.  Fluorescence intensities of transcription sites 
were determined by 2D Gaussian fitting on processed image data. 
  
Mathematical modeling 
Mathematical models were constructed and simulations were performed in Matlab using Gillespie’s 
stochastic simulation algorithm222. For the ‘polymerase binding occurs in bursts’ model, genes 
could be in three states (closed, open, polymerase bound). A gene in the closed (off, non-burst 
initiated) state transitions to the open (bursting) state at the burst initiation rate, while a gene in the 
open state can have polymerase bind the promoter with the polymerase binding rate. Once a 
polymerase is bound, that polymerase can be released to elongation with the rate of polymerase 
release from pausing, and the promoter thus returns to the open and unbound state. From either 
the open unbound or open polymerase bound state, the gene can transition to the off state with the 
rate of burst termination. We varied each of these rates through a 1000 fold range of values (as 
shown in Figure A3.3E). Other model variations (‘polymerase pause release occurs in bursts’, 
telegraph, ‘bind-release’, ‘polymerase binding occurs in bursts with refractory period’, and 
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‘polymerase binding occurs in bursts with possibility of termination from pause release site’) had 
different transition possibilities dictated by the frameworks displayed in Figures A3.2 and A3.3. 
For every set of rates in a given model, we simulated 1000 gene copies, which were allowed to 
proceed through 2000 changes in state. We recorded the state of each gene copy at 1500 time 
intervals. The simulation equilibrated away from the initial condition (every gene copy started in the 
‘off’ state) for every property within this time window, typically after ~100-200 time steps, and the 
value at which it converged was used for the following analyses. Each time a gene underwent the 
pause release (or RNA production) step, we allowed that polymerase to produce 1 RNA and 
elongate along the gene body for a short, fixed amount of time, and then for the polymerase to fall 
off the gene body and the nascent RNA to no longer be detected by RNA FISH. We then used the 
above information to calculate: transcription sites per cell (proportion of gene copies with at least 1 
polymerase elongating in the gene body at a given time); transcription site intensity (average 
number of elongating polymerases on one gene for gene copies with at least 1 polymerase 
elongating in the gene body at a given time), polymerase binding signal at promoter (proportion of 
gene copies in the pol2 bound state), polymerase binding signal at gene body (average number of 
Pol molecules in the gene body). We calculated Pol II traveling ratio as gene body polymerase 
signal divided by promoter polymerase signal. (Note that none of these measures rely on identifying 
the beginning and end of a ‘burst’: if bursts are frequent enough, they will run together, leading to 
all gene copies being transcribed (maximum of 2 gene copies per cell) and leading to increased 
transcription site intensity). 
  
Figure generation, plotting and graphics 
We used R packages dplyr and ggplot2 to produce nearly all figures, followed by cosmetic 
adjustments in Adobe Illustrator. All code to perform modeling, data analysis and figure generation 
is available in Dropbox 
(https://www.dropbox.com/sh/ti5lfcn0e71p45i/AAD64o4EM6v3_1Gw3_88XuBza?dl=0). 
 
74 
 
CHAPTER 4: Discussion 
 
4.1 The goal of my thesis work: using the lens of transcriptional bursting to improve our 
model of transcriptional regulation 
In my graduate work, I asked how the phenomenon of transcriptional bursting might change 
the field’s understanding of transcriptional regulation. Transcriptional bursting was first described 
relatively recently163,203, when the field of transcriptional regulation was well-established, and this 
surprising observation provided the field new information about how transcription operates. 
However, there has been a lack of studies re-examining our previous long-standing and 
mechanistic understanding of transcription in light of these new developments. 
Many of the first studies examining transcriptional bursting mainly addressed how the observed 
properties of bursting, such as burst frequency and intensity, were modulated in different cell 
types in response to different stimuli. Such studies clearly demonstrated that the properties of 
bursting could be regulated, but failed to address how bursting was regulated on a molecular 
level. Conversely, biochemical-based studies of transcription typically ignored the finding of 
transcriptional bursting when trying to advance our understanding of transcriptional regulation. 
Some studies seemed to recognize this gap between the observation of transcriptional bursting 
and our previous models of transcriptional regulation: studies sometimes alluded to the 
phenomenon of bursting, and suggest that it related to their findings156,241, but in many cases this 
was a theoretical discussion, without actual experimental examination of bursting in their system. 
This gap between the rich history of transcriptional regulation studies, and the young field of 
transcriptional bursting observations, was the gulf that my thesis work set out to address. We 
realized that given the extensive examination of transcriptional regulation in many systems, it was 
likely that molecular players involved in bursting regulation were previously identified in 
biochemical approaches. In effect, transcriptional bursting had always been present in 
biochemical studies of transcription with approaches like ChIP-seq and PRO-seq; such studies 
could not measure this phenomenon due to the averaging effects of combining millions of cells. 
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However, bursting was an inextricable part of transcription: if one could identify a way to reduce 
either the frequency or amplitude of a gene’s bursts to zero, transcription would be blocked, even 
in assays that couldn’t detect bursting at all. Thus, we hypothesized that by separating out which 
molecular processes might regulate bursting, imaging-based studies of transcriptional bursting 
might add information to disentangle how transcription is regulated. 
 
4.2 Perspectives on enhancer regulation of transcriptional burst frequency 
 We reasoned that the best way to identify the regulation of transcriptional bursting was to 
measure transcriptional bursting in a system that was well-characterized from a biochemical 
perspective of transcription, thereby giving us the tools to identify how to connect transcriptional 
bursting to known regulation of transcription. I thus began my Ph.D. by examining the 
transcriptional bursting of the beta-globin locus during erythroid differentiation. Using the zinc-
finger-based forced looping approach previously developed in the Blobel lab79,112, I found that in 
both mouse and primary human erythroblasts, enhancer-promoter contact controlled the fraction 
of time the beta-globin gene transcribed, without changing the transcriptional intensity. This work 
identified a connection between a known biochemically-measurable process required for 
transcription, enhancer-promoter contact, and an isolated property of bursting (schematic in 
Figure 4.1). 
Satisfyingly, an independent study published at the same time in an unrelated system 
confirmed that enhancer-promoter contact modulated burst frequency without changing burst 
size232. In this study, Fukaya and colleagues used the MS2 technology, which enables 
fluorescent labeling of a genetically-tagged nascent RNA in live cells, to measured bursting in 
transgenes in Drosophila melanogaster. They found that either increasing the distance between 
an enhancer and its target transgene, or separating the enhancer and transgene with an insulator 
sequence, decreased the burst frequency of the reporter gene without changing the burst 
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intensity. They confirmed this finding with several different and unrelated enhancer sequences. In 
effect, the main finding of both studies was in agreement. 
 
Figure 4. 1: Schematic of findings in Bartman et al. 2016. Forced enhancer-promoter looping 
increased burst fraction at the beta-globin locus, while erythroid maturation both increased burst fraction and 
burst intensity. 
One interesting inconsistency between our study and Fukaya et al. related to the 
phenomenon of promoter competition for enhancer activity. A longstanding question in the field of 
transcriptional regulation has been whether an enhancer can only drive one gene at a time, and 
thus if driving multiple target genes by the same enhancer would effectively divide the power of 
that enhancer 4,18,114,115. Given the prevalence of enhancers that contact multiple genes detected 
by chromosome conformation capture approaches, and of genes that contact multiple enhancers, 
understanding how such complex regulatory systems work may be important to understanding 
transcriptional regulation in cells99,119,125. Moreover, the phenomenon of bursting could be 
suggested to be a solution to the challenge of regulating multiple target genes with one enhancer: 
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rather than enhancer-promoter networks forming complex rosette-like structures in every cell76,77, 
an alternate possibility was that enhancer-promoter contacts were relatively dynamic, and thus an 
enhancer could switch between driving different promoters on the minutes-to-hours timescale on 
which transcriptional bursts occur. In the human beta-globin system which we studied, the same 
enhancer, known as the globin locus control region (LCR), is required for the transcription of both 
adult and fetal beta-type globins, which in culture can be transcribed in the same cell population. 
We examined the transcription of fetal and adult globin in primary human red blood cell 
precursors, and found that these two genes could be transcribed simultaneously by the same 
gene copy in the same cell (i.e. one of the 2 copies in a G1 cell, 4 copies in a G2 cell). Statistical 
analysis showed that these gene copies were cotranscribed slightly less than would be predicted 
if their transcription was statistically independent. (Moreover, our measurements of transcriptional 
bursts using RNA FISH in fixed cells had by necessity a slight lag, since transcription sites were 
detectable for around 5-10 minutes after transcription was blocked (see Figure A2.1), and thus 
true cotranscription of the two genes was likely less than what we measured by RNA FISH.) We 
concluded that we could observe a slight effect of promoter competition for enhancers. In 
dramatic contrast, Fukaya and colleagues found that when they created a transgene where an 
enhancer was placed equidistant between two promoters, these promoters were actually highly 
likely to transcribe simultaneously. This same group went on to show that, in fact, an enhancer 
could drive simultaneous transcription between target promoters on different chromosomes in 
Drosophila, one promoter on the same chromosome as the enhancer and one on the 
homologous chromosome. This observation was very surprising, and different from our findings in 
mouse and human systems. Moreover, this observation has been cited extensively to support a 
phase-separation model of transcription in which active enhancers and promoters condense 
together (in effect, a fancy modern version of the rosette model), so it may be important to 
investigate this finding further. 
Several possibilities for these different observations of enhancer-multiple-promoter 
transcription exist. The genes in the Fukaya et al. study were artificial transgenes in Drosophila 
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embryos measured in live cells, while ours were endogenous, non-genetically-manipulated loci in 
mammalian systems measured in fixed cells. Drosophila have been previously observed to have 
the ability for enhancers to drive transcription on neighboring chromosomes, known as 
transvection242, while this is probably not common in mammalian systems. Moreover, 
transcription in Drosophila embryos may be qualitatively distinct from mammalian transcription in 
the sense that Drosophila genes are extremely highly transcribed, and rarely have pauses 
between bursts, while in mammalian cell culture most genes are transcribed less than 50% of the 
time168. Moreover, a different imaging-based study in Drosophila did observed promoter 
competition in a reporter system187, suggesting that the finding of coordinated transcription of 
promoters may even be unusual in that species. Further studies will be required to see if this 
simultaneous bursting behavior of promoters driven by the same enhancers is specific to the 
transgene system of Fukaya et al., this developmental stage, or Drosophila in general, or 
alternatively whether other mammalian loci might exhibit such simultaneous bursting behavior 
and beta-globin is simply an exception. 
The finding that enhancer-promoter looping controls burst frequency, the main conclusion of 
our study and the study of the Levine group, has been further investigated in the two years since 
these studies were published. One beautiful study in the Drosophila system supported this finding 
and in fact illustrated it more directly: they were able to use genetic engineering and multicolor 
live imaging to visualize the DNA regions of the enhancer and the promoter of a Drosophila 
transgene, as well as nascent RNA from the transgene85. Using this system, they found that 
enhancer-promoter contact controlled transcriptional burst frequency, and indeed they saw 
directly that transcription could only occur after the enhancer had contacted the promoter, and 
then transcription halted when the enhancer region moved away from the promoter in the 
nucleus. However, other studies have shown conflicting findings. Notably, one preprint that 
imaged the Sox2  enhancer region, its target gene and the gene’s nascent RNA in embryonic 
stem cells found that transcriptional bursts occurred without the enhancer approaching the 
promoter243. One possibility is that the regulation of this locus and the beta-globin locus are 
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fundamentally different in their regulation; a more interesting possibility is that enhancer-promoter 
looping could be correlated with, but not required for, a different event that is the proximal cause 
of burst initiation. Such a second event could be nucleosome remodeling, recruitment of Mediator 
or other activation proteins, or another event. Future work in our lab, described below, will 
hopefully help disentangle how exactly a transcriptional burst is begun. 
 
4.3 Perspectives on transcriptional burst initiation as a key control point of transcriptional 
regulation and subsequent studies in the field 
 My first study identified a molecular regulator of an aspect of bursting, namely that 
promoter-enhancer contact at the beta-globin locus controlled burst frequency. But this finding 
raised as many questions as it answered. First, in differentiating erythroid cells, cellular 
differentiation increased enhancer-promoter contact at the beta-globin locus; in contrast, erythroid 
differentiation increased both burst fraction and burst intensity of beta-globin transcription. Thus, it 
was unclear which of the many global or locus-specific changes occurring during erythroid 
differentiation might be responsible for the increase in beta-globin burst intensity. Moreover, we 
wondered how such burst frequency modulation by enhancer contact might fit in with the 
numerous other modes of transcriptional regulation previously characterized4,8,60. Previous 
studies have suggested that enhancers might regulate multiple different aspects of transcription, 
including polymerase recruitment or polymerase pause release4,8,72,73. In effect, identifying that 
enhancer-promoter contact regulated transcriptional burst frequency still failed to clarify exactly 
what was happening at a target gene when a transcriptional burst occurred. Relatedly, some 
studies had theorized that when a transcriptional burst began, it then allowed polymerase to be 
recruited to a gene, while others had hypothesized that bursting could consist of ‘bursts’ of 
promoter-proximal pause release149,156. On the other hand, many studies that imaged 
transcriptional bursts ignored the step of pause release altogether, in spite of evidence that it was 
an important transcriptional checkpoint177. Finally, the majority of transcriptional bursting studies 
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focused on one or a few loci, which often were genetically modified to enable imaging of 
transcription, while we were well-placed to use RNA FISH to measure the transcription of a wide 
variety of intact endogenous loci. We set out to resolve how transcriptional burst regulation fit in 
with polymerase binding and pause release regulation. 
 We sought to reconcile biochemically-measured Pol II dynamics with bursting behaviors 
to create a more holistic model of transcription. To this end, we performed both types of 
measurements on the same cell population. We reasoned that since Pol II ChIP-seq and bursting 
both measured transcription with orthogonal techniques, they would be expected to correlate in 
predictable ways. Moreover, we realized that the patterns of correspondence between the two 
technologies actually provided information about how the underlying transcriptional behavior was 
regulated. In an ideal world, we would be able to perform live imaging of single Pol II molecules 
transcribing RNA on single gene copies, and thus directly measure how polymerase recruitment 
and pause release relate to pulsatile RNA transcription in endogenous, non-genetically-
engineered loci. As a substitute, we used the technologies of Pol II ChIP-seq and nascent 
transcript RNA FISH to infer such dynamics. 
 We first considered how underlying transcription in a population of cells would be 
reflected in both Pol II ChIP-seq and RNA FISH measurements. For example, Pol II ChIP-seq is 
an average of polymerase binding averaged across a population of cells.  On any given gene 
copy, theoretically, we might expect there to be no polymerase at all, or a polymerase paused 
near the promoter, or a polymerase or multiple molecules of polymerase elongating in the gene 
body. (Recent studies have shown that given the size of the Pol II initiation complex, only a single 
Pol II molecule can sit in the promoter-proximal region156,157, so we built this requirement into our 
model.) Thus, if we simulated many copies of a gene in various different transcriptional states, 
averaging all of these together should yield a simulated Pol II ChIP-seq profile. Nascent transcript 
RNA FISH applied to the same population of gene copies would yield a different type of result: 
first, it would be able to measure the state of every gene copy in the 
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Figure 4. 2 Marble raceway schematic of transcriptional models investigated in Bartman et al. 
2018. A) Polymerase binding occurs in bursts model: models are schematized as marble raceways, in 
which each step of transcription is a ‘gate’ that a polymerase has to pass by in order to reach the next step 
and ultimately to elongate through the gene body. Each time a polymerase (marble) passes a final gate and 
rolls to the end, 1 RNA is produced in the model. In this model, the rates of three gates opening can be 
regulated: the blue gate blocks access to the green gate (i.e. burst has to initiated before polymerase can 
bind). This model was consistent with our experimental data. B) Polymerase pause release occurs in burst 
model: in this model, the blue gate is after the green gate but before the red gate (i.e. polymerase can bind 
anytime, but polymerase can only undergo pause release after burst initiation. This model was not 
consistent with our experimental data. C) Binding-release model: polymerase has to bind, and then 
polymerase has to undergo pause release before it can elongate. This model was not consistent with our 
experimental data. 
population, rather than yielding an average. However, both gene copies with no polymerase, or 
gene copies with polymerase paused at the promoter, would yield no signal in this assay. A 
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nascent transcript RNA FISH signal should appear at genes with at least one polymerase 
elongating and producing RNA at the time the cells were fixed, and the fluorescence intensity of 
the FISH signal should correlate to the number of polymerase molecules that had produced 
nascent RNAs in the past 5 minutes or so before fixation.  
 We then used these strictures to create multiple mathematical models of transcription 
(Figure A3.3, Figure 4.1). These models turned out to be critical for our conclusions: we had 
started out trying to make intuitive predictions for how transcriptional steps might have behaved, 
but this became untenable and confusing; in contrast, by setting up models, we had concrete 
predictions we could accept or reject using experimental data. For each model, we varied the 
rates of each included step of transcription, and predicted how each type of transcriptional  
change should be predicted to alter both Pol II ChIP-seq measurements and nascent transcript 
RNA FISH measurements of transcriptional bursting. We found that, depending on the way that 
transcription could be changed by varying different rates in the model, different experimental 
behaviors of these two methods were predicted to appear, suggesting that if we could 
experimentally measure the possible range of transcriptional measurements, we could see which 
mathematical model would line up to those possibilities, and thus we could infer which steps of 
transcription must be regulated in our system. 
 To complement this modeling approach, we performed a number of transcriptional 
perturbations in the mouse erythroid cell line used in the previous study, and measured the 
experimental changes in a number of different genes, in order to try to capture the full range of 
transcriptional behaviors possible in this system. We eventually examined 15 different genes, 
including of housekeeping genes, hematopoietic stem cell genes, and erythroid-specific induced 
genes, and examined their changes in response to a number of perturbations including different 
transcriptional inhibitors and genetic enhancer dissection. The ability to examine such a range of 
genes and perturbations set our study apart from previous studies. 
 We then compared our range of experimental observations to the different possible 
behaviors predicted by our computational models of transcription. Our previous finding, that burst 
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fraction could be controlled without any change to burst intensity, turned out to be key to this 
analysis, along with several other perturbation-gene pairings we found that resulted in 
independent change in burst fraction (Figure 3.2A, 3.3A). Specifically, previous literature could be 
taken to suggest that polymerase recruitment and polymerase pause release were the main 
regulated steps of transcription4,58. However, a computational model where only these two steps 
could be modulated predicted that burst fraction and burst intensity would always change in 
tandem, and thus such a model was inconsistent with our experimental findings. On the other 
hand, previous discussion had theorized that bursts might appear because polymerase binding 
occurred in a pulsatile manner, or alternatively because polymerase pause release occurred in a 
pulsatile manner156,241. We showed that our data were inconsistent with the latter model. 
Specifically, if polymerase pause release occurred in a pulsatile manner, then burst fraction 
changes would be predicted to move in tandem with the Pol II traveling ratio, or the amount of Pol 
II able to be released from the promoter proximal region, but in contrast, we never saw a change 
in the Pol II traveling ratio in the situations where burst fraction changed without burst intensity 
(see Figures 3.1F, 3.2A, 3.4A). Thus, applying a range of perturbations to a range of genes, and 
then measuring them with two orthogonal experimental approaches, was required for our 
conclusion that burst frequency could be controlled by an independent ‘burst initiation’ step, and 
that burst initiation controlled the ability of polymerase to bind the promoter rather than the ability 
of polymerase to be released from promoter-proximal pausing. 
 The combination of two experimental approaches to measure transcription helped us to 
draw conclusions about the underlying transcriptional behavior; analogously, it enabled us to 
propose explanations for how our conclusions might contrast to previous findings in the field. For 
example, most studies examining transcriptional bursting relied on the ‘telegraph model’ of 
transcription. In this model, the only two regulated steps are burst initiation, and then ‘RNA 
production’, which is an unspecified hybrid step combining polymerase recruitment, polymerase 
pause release, and any other step required to make RNA molecules. This model has been useful 
for the field because it can satisfactorily model the distribution of messenger RNA molecules in a 
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population of cells measured by RNA FISH or RNA live imaging163,166,178. However, we were able 
to show that to understand how stimuli regulate transcription, Pol II ChIP-seq is required also (or 
another similar technique); using such a method revealed that polymerase pause release is a 
dominant mode of transcriptional regulation, a more molecularly specific finding than regulation of 
‘RNA production’. We came to this conclusion by showing that most stimuli including erythroid 
differentiation and BET protein inhibition change Pol II traveling ratio, similar to an inhibitor of 
pause release and consistent with model-predicted effect of changing pause release, and 
inconsistent with experimental or model-predicted changes to polymerase recruitment.  
 Conversely, we showed that an independent burst initiation step upstream of polymerase 
binding rate can be a regulated step of transcription, for example when promoter-enhancer 
contact is modulated. Both modeling predictions and inhibitor experiments confirmed that the 
effect of promoter-enhancer contact was distinct from the effect of changing either polymerase 
recruitment or polymerase pause release. Our modeling showed that, from the standpoint of 
population averaging methods such as Pol II ChIP-seq, changes in burst initiation would be 
indistinguishable from changes in polymerase recruitment. We hypothesize that many studies 
that have pointed to changes in polymerase recruitment using bulk methods may have actually 
been measuring changes to burst initiation. Thus, for studies aiming to disentangle transcriptional 
mechanisms in future it will be important to combine single-cell approaches to distinguish effects 
on burst initiation from effects on polymerase recruitment. 
 
4.4 Future Directions 
 Many unanswered questions related to the regulation of transcriptional bursting persist.  
One interesting future arena concerns the concept of phase separation. There is mounting 
evidence that condensation of proteins, mediated by disordered domains, might be critical to or at 
least correlated with active transcription (discussed in the Introduction)18,34,38. Indeed, the Fukaya 
et al. study showing tandem bursting of promoters controlled by the same enhancer has been 
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used as support for such a model18. Whether transcription in general, and the control of 
transcriptional bursting in particular, requires such a phase separation mechanism will be difficult 
to disentangle, but perhaps will shed light on new transcriptional mechanisms. 
Another future direction directly proceeding from my studies is the molecular identity of the 
‘burst initiation’ step that must occur upstream of polymerase binding. Our studies of the beta-
globin locus suggested that this step was controlled by promoter enhancer looping, and this idea 
is strongly supported by the Gregor result that enhancer-promoter contact is necessary, 
independent from, and upstream of RNA transcription85. However, the Sox2 study suggests that 
at the very least promoter-enhancer looping may not directly control burst initiation in all 
systems243. Future work in the Raj and Blobel labs will hope to address this issue. The Raj lab 
has developed a technique to sort cells expressing an RNA of interest from a population244. We 
will optimize this technique to allow specific enrichment of actively bursting cells from a population 
of unmanipulated cells, since for even highly expressed genes 50% or less of gene copies are 
actively transcribing at any given time (for example, see Figure 2.1D). This purification method 
will allow us to compare biochemical properties of a gene locus of interest in actively bursting and 
nonbursting cells. For example, we will perform chromatin conformation capture in transcribing 
and nontranscribing cells: if promoter-enhancer contact directly causes burst initiation, then 
promoter-enhancer contact should be strongly elevated in transcribing compared to non-
transcribing cells in a population. Other candidates for burst initiation causation will be examined, 
including nucleosome remodeling, promoter binding by a transcription factor, and histone 
modification. 
More broadly, high resolution live imaging is becoming more advanced to the point where it 
can be informative as to the events regulating transcription38,187. It will be exciting to see such 
techniques advance and be applied to clarify the sequence of events occurring during 
transcription. 
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